#BEGIN_DRUGCARD DB04447

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
18320

# Chemical_Formula:
C4H10O2S2

# Chemical_IUPAC_Name:
(2S,3S)-1,4-disulfanylbutane-2,3-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1,4-Dithiothreitol

# HET_ID:
DTT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m1/s1

# InChI_Key:
InChIKey=VHJLVAABSRFDPM-QWWZWVQMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4447

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
154.251

# Molecular_Weight_Mono:
154.012220944

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1R43

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.18

# Predicted_LogS:
-1.5

# Predicted_Water_Solubility:
5.14e+00 g/l

# Primary_Accession_No:
DB04447

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
446094

# PubChem_Substance_ID:
46505212

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01291

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@H](CS)[C@H](O)CS

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:20 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Cytoplasm

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
L17082

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
pcaB

# Drug_Target_10_Gene_Sequence:
>1224 bp
ATGACCAACCAACTGTTCGACGCCTACTTCACCGCGCCGGCCATGCGCGAGATTTTCTCC
GACCGTGGCCGCTTGCAGGGCATGCTCGATTTCGAAGCCGCGCTGGCCCGTGCCGAAGCT
GCTGCGGGGCTGGTCCCGCACAGCGCCGTGGCCGCCATCGAGGCGGCATGCAAGGCCGAG
CGCTATGACGTGGGGGCGCTGGCCAATGCCATCGCAACCGCTGGCAACTCGGCAATCCCG
CTGGTGAAGGCGTTGGGCAAGGTGATTGCCAGTGGCGTGCCCGAGGCCGAGCGCTATGTG
CACTTGGGCGCCACCAGCCAGGACGCGATGGACACCGGTCTGGTGTTGCAGTTGCGCGAT
GCCCTCGACCTGATCGAAGCGGACCTGGGCAAACTGGCCGATACCCTGTCGCAGCAGGCA
TTGAAGCACGCCGATACGCCAATGGTGGGCCGCACCTGGCTGCAACACGCTACCCCGGTG
ACCCTGGGCATGAAACTGGCTGGCGTGCTGGGGGCATTGACCCGCCACCGTCAGCGCCTG
CAAGAGCTCGGCCCGCCCTGTTGGTGCTGCAGTTCCGGCGGCGCCTCGGGCAGCCTGGCC
GCTCTGGGCAGCAAGGCGATGCCGGTGGCCGAGGCCCTGGCCGAGCAACTGAAGCTGAGC
CTGCCCGAGCAACCCTGGCACACCCAGCGTGATCGCCTGGTGGAGTTTGCCTCGGTGCTG
GGCCTTGTGGCCGGCAGCCTGGGCAAGTTCGGCCGCGATGTCAGCCTGCTGATGCAAACC
GAGGCGGGGGAGGTGTTCGAGCCTTCTGCACCAGGCAAGGGCGGCTCCTCGACCATGCCA
CACAAGCGCAACCCGGTGGGCGCTGCGGTGCTGATCGGTGCCGCGACTCGCGTGCCGGGG
CTGGTATCGACGCTGTTCGCCGCCATGCCCCAGGAGCACGAGCGCAGCCTGGGCCTGTGG
CATGCCGAATGGGAAACCCTCCCGGACATCTGCTGCCTGGTCTCCGGCGCGCTGCGCCAG
GCCCAGGTCATTGCCGAGGGCATTGAAGTAGACGCAGCGCGCATGCGCCGTAACCTCGAC
CTGACCCAAGGGCTGGTGCTGGCAGAAGCGGTGAGTATCGTCCTGGCCCGAACGCCTGGG
CCGCGACCGTGCCCACCACTTGCTGGAGCAATGCTGCCAGCGAGCCGTGGCCGAACAGCG
GCACCTGCGTGCGGTGCTGGGTGA

# Drug_Target_10_General_Function:
Involved in catalytic activity

# Drug_Target_10_General_References:
1390752	Williams SE, Woolridge EM, Ransom SC, Landro JA, Babbitt PC, Kozarich JW: 3-Carboxy-cis,cis-muconate lactonizing enzyme from Pseudomonas putida is homologous to the class II fumarase family: a new reaction in the evolution of a mechanistic motif. Biochemistry. 1992 Oct 13;31(40):9768-76.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
5599

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
44677

# Drug_Target_10_Name:
3-carboxy-cis,cis-muconate cycloisomerase

# Drug_Target_10_Number_of_Residues:
422

# Drug_Target_10_PDB_ID:
1RE5

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00206	Lyase_1

# Drug_Target_10_Protein_Sequence:
>3-carboxy-cis,cis-muconate cycloisomerase
MTNQLFDAYFTAPAMREIFSDRGRLQGMLDFEAALARAEAAAGLVPHSAVAAIEAACKAE
RYDVGALANAIATAGNSAIPLVKALGKVIASGVPEAERYVHLGATSQDAMDTGLVLQLRD
ALDLIEADLGKLADTLSQQALKHADTPMVGRTWLQHATPVTLGMKLAGVLGALTRHRQRL
QELGPPCWCCSSGGASGSLAALGSKAMPVAEALAEQLKLSLPEQPWHTQRDRLVEFASVL
GLVAGSLGKFGRDVSLLMQTEAGEVFEPSAPGKGGSSTMPHKRNPVGAAVLIGAATRVPG
LVSTLFAAMPQEHERSLGLWHAEWETLPDICCLVSGALRQAQVIAEGIEVDAARMRRNLD
LTQGLVLAEAVSIVLARTLGRDRAHHLLEQCCQRAVAEQRHLRAVLGDDPQVSAELSAEE
LD

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Catalyzes an anti cycloisomerization

# Drug_Target_10_SwissProt_ID:
P32427

# Drug_Target_10_SwissProt_Name:
PCAB_PSEPU

# Drug_Target_10_Synonyms:
3- carboxymuconate lactonizing enzyme
CMLE
EC 5.5.1.2

# Drug_Target_10_Theoretical_pI:
5.93

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
Not Available

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
TRPM7

# Drug_Target_11_Gene_Sequence:
Not Available

# Drug_Target_11_General_Function:
Not Available

# Drug_Target_11_General_References:
Not Available

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
7134

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
Not Available

# Drug_Target_11_Name:
Transient receptor potential cation channel subfamily M member 7

# Drug_Target_11_Number_of_Residues:
0

# Drug_Target_11_PDB_ID:
Not Available

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
Not Available

# Drug_Target_11_Protein_Sequence:
Not Available

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
Not Available

# Drug_Target_11_Specific_Function:
Not Available

# Drug_Target_11_SwissProt_ID:
Q96QT4

# Drug_Target_11_SwissProt_Name:
TRPM7_HUMAN

# Drug_Target_11_Synonyms:
Not Available

# Drug_Target_11_Theoretical_pI:
Not Available

# Drug_Target_11_Transmembrane_Regions:
Not Available

# Drug_Target_12_Cellular_Location:
Cytoplasm

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
AB019619

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
ugl

# Drug_Target_12_Gene_Sequence:
>1134 bp
ATGTGGCAGCAAGCGATAGGCGACGCGCTCGGCATTACCGCCCGCAATCTCAAGAAATTC
GGGGACCGTTTCCCCCATGTCAGCGACGGGAGCAACAAGTACGTGCTGAACGACAATACC
GACTGGACAGACGGTTTCTGGTCCGGCATCCTGTGGCTCTGCTACGAATATACGGGAGAC
GAGCAATACCGCGAGGGCGCCGTCCGGACGGTCGCGAGCTTCCGCGAACGTCTGGATCGT
TTCGAGAATCTCGATCATCACGACATCGGCTTCCTATACTCGCTGTCGGCCAAGGCCCAA
TGGATCGTCGAAAAGGACGAATCCGCGCGCAAGCTGGCGCTCGATGCCGCCGACGTGCTG
ATGCGCCGCTGGCGCGCGGATGCGGGCATTATCCAGGCCTGGGGACCGAAGGGCGATCCG
GAAAACGGCGGACGCATCATCATCGACTGCCTGCTGAATCTGCCGCTTTTGCTCTGGGCC
GGCGAACAGACGGGCGATCCCGAATACCGCCGCGTCGCCGAGGCGCACGCGCTGAAAAGC
CGCCGGTTCCTCGTGCGCGGCGACGATTCGAGCTATCATACGTTCTACTTCGACCCAGAA
AACGGGAATGCCATCCGCGGCGGCACGCACCAGGGCAACACCGACGGCAGCACGTGGACG
CGCGGCCAGGCTTGGGGCATCTACGGCTTCGCGTTGAACAGCCGCTATCTCGGCAATGCC
GACCTGCTGGAGACGGCGAAGCGCATGGCGCGCCACTTCCTCGCCCGGGTGCCGGAGGAC
GGCGTCGTGTATTGGGACTTCGAGGTGCCGCAGGAGCCGTCCTCGTACCGAGACAGCTCC
GCGTCGGCCATCACGGCATGCGGCCTGCTCGAGATCGCGAGCCAGCTTGACGAGAGCGAC
CCCGAGCGCCAGCGCTTCATCGACGCGGCGAAGACGACCGTGACGGCGCTGCGCGACGGC
TACGCCGAGCGCGACGACGGCGAAGCCGAAGGCTTCATCCGCCGCGGCTCCTATCACGTG
CGCGGCGGCATCTCGCCCGACGACTACACGATCTGGGGCGATTATTATTACCTGGAAGCG
CTGCTGCGTCTGGAGCGCGGCGTGACGGGGTATTGGTACGAGCGCGGACGTTAA

# Drug_Target_12_General_Function:
Involved in catalytic activity

# Drug_Target_12_General_References:
10441389	Hashimoto W, Kobayashi E, Nankai H, Sato N, Miya T, Kawai S, Murata K: Unsaturated glucuronyl hydrolase of Bacillus sp. GL1: novel enzyme prerequisite for metabolism of unsaturated oligosaccharides produced by polysaccharide lyases. Arch Biochem Biophys. 1999 Aug 15;368(2):367-74.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
5410

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
42862

# Drug_Target_12_Name:
Unsaturated glucuronyl hydrolase

# Drug_Target_12_Number_of_Residues:
377

# Drug_Target_12_PDB_ID:
1VD5

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF07470	Glyco_hydro_88

# Drug_Target_12_Protein_Sequence:
>Unsaturated glucuronyl hydrolase
MWQQAIGDALGITARNLKKFGDRFPHVSDGSNKYVLNDNTDWTDGFWSGILWLCYEYTGD
EQYREGAVRTVASFRERLDRFENLDHHDIGFLYSLSAKAQWIVEKDESARKLALDAADVL
MRRWRADAGIIQAWGPKGDPENGGRIIIDCLLNLPLLLWAGEQTGDPEYRRVAEAHALKS
RRFLVRGDDSSYHTFYFDPENGNAIRGGTHQGNTDGSTWTRGQAWGIYGFALNSRYLGNA
DLLETAKRMARHFLARVPEDGVVYWDFEVPQEPSSYRDSSASAITACGLLEIASQLDESD
PERQRFIDAAKTTVTALRDGYAERDDGEAEGFIRRGSYHVRGGISPDDYTIWGDYYYLEA
LLRLERGVTGYWYERGR

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Catalyzes the hydrolysis of oligosaccharides with unsaturated glucuronyl residues at the nonreducing terminal, to a sugar or an amino sugar, and an unsaturated D-glucuronic acid (GlcA), which is nonenzymatically converted immediately to alpha- keto acid

# Drug_Target_12_SwissProt_ID:
Q9RC92

# Drug_Target_12_SwissProt_Name:
UGL_BACGL

# Drug_Target_12_Synonyms:
EC 3.2.1.-
Glycosaminoglycan hydrolase
Glycuronidase
UGL
Unsaturated uronic acid hydrolase

# Drug_Target_12_Theoretical_pI:
4.93

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
BA000033

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
moaA

# Drug_Target_13_Gene_Sequence:
>1023 bp
TTAACCACCAATATAATTCATGTTTATCTTTTTACGTTGACGATTGGCAACTGTTTGAGC
AGTTCTCTCATCTGAATATCGATCATCTCTTATTTGCCATAAAGCTTTAAATTGTTCTTT
TAATTCTTCGTCGGTCACGCCAGAACGAATAAACGCTTTAACGTTAAATCCATCGACAGT
TGCAAATAAACATCCGTAAAACTTCCCATCTGATGACAGCCTTGCGCGTGTACATGTAGA
ACAAAATGATTGTGAAACACTTGTAATCAAACCAAATTGAACACCATTATCCTTATGGCG
ATAATATTTTGCTACTTCCCCAAAATATTTTGGTTCTACAGGATCGATTTCAAAGTGCTG
CTCTATCATTGTAAGCATTTCATCTTTAGTTACAACTTTACTGAAATCCCATCCATTATC
ATTACCAACATCCATAAATTCTATAAATCGAATCTCTATATGTTTATCTTTAAAATATTC
AAGCATTGGTATGATTTGATCATCGTTAATACCTTTTTGTATAACAACATTTACTTTTAC
ATTCAAACCAATAGACGTCGCGTAATCAATTTGTTCTAAAATCGTAGTCGCTTTAATATT
ACGATTATTGATTGATTGAAATAGCGTATCATCAATAGCATCCAAACTGACATTAATTCT
GCGCAGCCCAGCATCATATAACTTTTGTCCATGCTTTTTTAATAACAAACCATTTGTAGT
CAAACCAATATCTTCAATACCATCGATTTGATTTAATTTAGCTATAAGTACATCTAAATC
CCGTCGCATCAATGGTTCTCCACCTGTAATGCGTATTTTTTTTACACCTAATTCTGCATA
TACCTTAGCGATTCTAGCCATTTCATCAAACGTTAAAAGTTCATTTTTAGGTAAAAATAC
GAAATCATCTCCAAATACCTCTTTAGGCATGCAATAATCACACCTAAAGTTACACCGATC
TGTCACAGATAACCGTAAGTCACGGATGGGACGTCCTAGTTTATCTTTTATTTGTTCTAC
CAT

# Drug_Target_13_General_Function:
Involved in catalytic activity

# Drug_Target_13_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
5672

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
39078

# Drug_Target_13_Name:
Molybdenum cofactor biosynthesis protein A

# Drug_Target_13_Number_of_Residues:
340

# Drug_Target_13_PDB_ID:
1TV8

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF04055	Radical_SAM
PF06463	Mob_synth_C

# Drug_Target_13_Protein_Sequence:
>Molybdenum cofactor biosynthesis protein A
MVEQIKDKLGRPIRDLRLSVTDRCNFRCDYCMPKEVFGDDFVFLPKNELLTFDEMARIAK
VYAELGVKKIRITGGEPLMRRDLDVLIAKLNQIDGIEDIGLTTNGLLLKKHGQKLYDAGL
RRINVSLDAIDDTLFQSINNRNIKATTILEQIDYATSIGLNVKVNVVIQKGINDDQIIPM
LEYFKDKHIEIRFIEFMDVGNDNGWDFSKVVTKDEMLTMIEQHFEIDPVEPKYFGEVAKY
YRHKDNGVQFGLITSVSQSFCSTCTRARLSSDGKFYGCLFATVDGFNVKAFIRSGVTDEE
LKEQFKALWQIRDDRYSDERTAQTVANRQRKKINMNYIGG

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Together with moaC, is involved in the conversion of a guanosine derivative (5'-GTP) into molybdopterin precursor Z (By similarity)

# Drug_Target_13_SwissProt_ID:
P65389

# Drug_Target_13_SwissProt_Name:
MOAA_STAAW

# Drug_Target_13_Synonyms:
Not Available

# Drug_Target_13_Theoretical_pI:
6.53

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Cell wall

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
Not Available

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
M97256

# Drug_Target_14_GenBank_ID_Protein:
Not Available

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
bca

# Drug_Target_14_Gene_Sequence:
>3063 bp
ATGTTTAGAAGGTCTAAAAATAACAGTTATGATACTTCACAGACGAAACAACGGTTTTCA
ATTAAGAAGTTCAAGTTTGGTGCAGCTTCTGTACTAATTGGTCTTAGTTTTTTGGGTGGG
GTTACACAAGGTAATCTTAATATTTTTGAAGAGTCAATAGTTGCTGCATCTACAATTCCA
GGGAGTGCAGCGACCTTAAATACAAGCATCACTAAAAATATACAAAACGGAAATGCTTAC
ATAGATTTATATGATGTAAAATTAGGTAAAATAGATCCATTACAATTAATTGTTTTAGAA
CAAGGTTTTACAGCAAAGTATGTTTTTAGACAAGGTACTAAATACTATGGGGATGTTTCT
CAGTTGCAGAGTACAGGAAGGGCTAGTCTTACCTATAATATATTTGGTGAAGATGGACTA
CCACATGTAAAGACTGATGGACAAATTGATATAGTTAGTGTTGCTTTAACTATTTATGAT
TCAACAACCTTGAGGGATAAGATTGAAGAAGTTAGAACGAATGCAAACGATCCTAAGTGG
ACGGAAGAAAGTCGTACTGAGGTTTTAACAGGATTAGATACAATTAAGACAGATATTGAT
AATAATCCTAAGACGCAAACAGATATTGATAGTAAAATTGTTGAGGTTAATGAATTAGAG
AAATTGTTAGTATTGTCAGTACCGGATAAAGATAAATATGATCCAACAGGAGGGGAAACA
ACAGTACCCCAAGGGACACCAGTTTCAGATAAAGAAATCACAGACTTAGTTAAGATTCCA
GATGGCTCAAAAGGGGTTCCGACAGTTGTTGGTGATCGTCCAGATACTAACGTTCCTGGA
GATCATAAAGTAACGGTAGAAGTAACGTATCCAGATGGAACAAAGGATACAGTAGAAGTA
ACGGTTCATGTGACACCAAAACCAGTACCGGATAAAGATAAATATGATCCAACAGGAGGG
GAAACAACAGTACCCCAAGGGACACCAGTTTCAGATAAAGAAATCACAGACTTAGTTAAG
ATTCCAGATGGCTCAAAAGGGGTTCCGACAGTTGTTGGTGATCGTCCAGATACTAACGTT
CCTGGAGATCATAAAGTAACGGTAGAAGTAACGTATCCAGATGGAACAAAGGATACAGTA
GAAGTAACGGTTCATGTGACACCAAAACCAGTACCGGATAAAGATAAATATGATCCAACA
GGAGGGGAAACAACAGTACCCCAAGGGACACCAGTTTCAGATAAAGAAATCACAGACTTA
GTTAAGATTCCAGATGGCTCAAAAGGGGTTCCGACAGTTGTTGGTGATCGTCCAGATACT
AACGTTCCTGGAGATCATAAAGTAACGGTAGAAGTAACGTATCCAGATGGAACAAAGGAT
ACAGTAGAAGTAACGGTTCATGTGACACCAAAACCAGTACCGGATAAAGATAAATATGAT
CCAACAGGAGGGGAAACAACAGTACCCCAAGGGACACCAGTTTCAGATAAAGAAATCACA
GACTTAGTTAAGATTCCAGATGGCTCAAAAGGGGTTCCGACAGTTGTTGGTGATCGTCCA
GATACTAACGTTCCTGGAGATCATAAAGTAACGGTAGAAGTAACGTATCCAGATGGAACA
AAGGATACAGTAGAAGTAACGGTTCATGTGACACCAAAACCAGTACCGGATAAAGATAAA
TATGATCCAACAGGAGGGGAAACAACAGTACCCCAAGGGACACCAGTTTCAGATAAAGAA
ATCACAGACTTAGTTAAGATTCCAGATGGCTCAAAAGGGGTTCCGACAGTTGTTGGTGAT
CGTCCAGATACTAACGTTCCTGGAGATCATAAAGTAACGGTAGAAGTAACGTATCCAGAT
GGAACAAAGGATACAGTAGAAGTAACGGTTCATGTGACACCAAAACCAGTACCGGATAAA
GATAAATATGATCCAACAGGAGGGGAAACAACAGTACCCCAAGGGACACCAGTTTCAGAT
AAAGAAATCACAGACTTAGTTAAGATTCCAGATGGCTCAAAAGGGGTTCCGACAGTTGTT
GGTGATCGTCCAGATACTAACGTTCCTGGAGATCATAAAGTAACGGTAGAAGTAACGTAT
CCAGATGGAACAAAGGATACAGTAGAAGTAACGGTTCATGTGACACCAAAACCAGTACCG
GATAAAGATAAATATGATCCAACAGGAGGGGAAACAACAGTACCCCAAGGGACACCAGTT
TCAGATAAAGAAATCACAGACTTAGTTAAGATTCCAGATGGCTCAAAAGGGGTTCCGACA
GTTGTTGGTGATCGTCCAGATACTAACGTTCCTGGAGATCATAAAGTAACGGTAGAAGTA
ACGTATCCAGATGGAACAAAGGATACAGTAGAAGTAACGGTTCATGTGACACCAAAACCA
GTACCGGATAAAGATAAATATGATCCAACAGGAGGGGAAACAACAGTACCCCAAGGGACA
CCAGTTTCAGATAAAGAAATCACAGACTTAGTTAAGATTCCAGATGGCTCAAAAGGGGTT
CCGACAGTTGTTGGTGATCGTCCAGATACTAACGTTCCTGGAGATCATAAAGTAACGGTA
GAAGTAACGTATCCAGATGGAACAAAGGATACAGTAGAAGTAACGGTTCATGTGACACCA
AAACCAGTACCGGATAAAGATAAATATGATCCAACAGGAGGGGAAACAACAGTACCCCAA
GGGACACCAGTTTCAGATAAAGAAATCACAGACTTAGTTAAGATTCCAGATGGCTCAAAA
GGGGTTCCGACAGTTGTTGGTGATCGTCCAGATACTAACGTTCCTGGAGATCATAAAGTA
ACGGTAGAAGTAACGTATCCAGATGGAACAAAGGATACAGTAGAAGTAACGGTTCATGTG
ACACCAAAACCAGTACCGGATAAAGATAAATATGATCCAACAGGTAAAGCTCAGCAAGTC
AACGGTAAAGGAAATAAACTACCAGCAACAGGTGAGAATGCAACTCCATTCTTTAATGTT
GCAGCTTTGACAATTATATCATCAGTTGGTTTATTATCTGTTTCTAAGAAAAAAGAGGAT
TAA

# Drug_Target_14_General_Function:
Not Available

# Drug_Target_14_General_References:
1438195	Michel JL, Madoff LC, Olson K, Kling DE, Kasper DL, Ausubel FM: Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10060-4.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
5673

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
108706

# Drug_Target_14_Name:
C protein alpha-antigen

# Drug_Target_14_Number_of_Residues:
1020

# Drug_Target_14_PDB_ID:
1YWM

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF00746	Gram_pos_anchor
PF04650	YSIRK_signal
PF08428	Rib
PF08829	AlphaC_N

# Drug_Target_14_Protein_Sequence:
>C protein alpha-antigen
MFRRSKNNSYDTSQTKQRFSIKKFKFGAASVLIGLSFLGGVTQGNLNIFEESIVAASTIP
GSAATLNTSITKNIQNGNAYIDLYDVKLGKIDPLQLIVLEQGFTAKYVFRQGTKYYGDVS
QLQSTGRASLTYNIFGEDGLPHVKTDGQIDIVSVALTIYDSTTLRDKIEEVRTNANDPKW
TEESRTEVLTGLDTIKTDIDNNPKTQTDIDSKIVEVNELEKLLVLSVPDKDKYDPTGGET
TVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEV
TVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNV
PGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDL
VKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYD
PTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGT
KDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGD
RPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSD
KEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVP
DKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEV
TYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQGTPVSDKEITDLVKIPDGSKGV
PTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHVTPKPVPDKDKYDPTGGETTVPQ
GTPVSDKEITDLVKIPDGSKGVPTVVGDRPDTNVPGDHKVTVEVTYPDGTKDTVEVTVHV
TPKPVPDKDKYDPTGKAQQVNGKGNKLPATGENATPFFNVAALTIISSVGLLSVSKKKED

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
1-41

# Drug_Target_14_Specific_Function:
May play a role in both virulence and immunity

# Drug_Target_14_SwissProt_ID:
Q02192

# Drug_Target_14_SwissProt_Name:
BCA_STRA1

# Drug_Target_14_Synonyms:
C protein alpha-antigen precursor

# Drug_Target_14_Theoretical_pI:
4.53

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Not Available

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
MSRA

# Drug_Target_15_GenBank_ID_Gene:
AJ242973

# Drug_Target_15_GenBank_ID_Protein:
6136945

# Drug_Target_15_GeneCard_ID:
MSRA

# Drug_Target_15_Gene_Name:
MSRA

# Drug_Target_15_Gene_Sequence:
>708 bp
ATGCTCTCGGCCACCCGGAGGGCTTGCCAGCTCCTCCTCCTCCACAGCCTCTTTCCCGTC
CCGAGGATGGGCAACTCGGCCTCGAACATCGTCAGCCCCCAGGAGGCCTTGCCGGGCCGG
AAGGAACAGACCCCTGTAGCGGCCAAACATCATGTCAATGGCAACAGAACAGTCGAACCT
TTCCCAGAGGGAACACAGATGGCTGTATTTGGAATGGGATGTTTCTGGGGAGCTGAAAGG
AAATTCTGGGTCTTGAAAGGAGTGTATTCAACTCAAGTTGGTTTTGCAGGAGGCTATACT
TCAAATCCTACTTATAAAGAAGTCTGCTCAGAAAAAACTGGCCATGCAGAAGTCGTCCGA
GTGGTGTACCAGCCAGAACACATGAGTTTTGAGGAACTGCTCAAGGTCTTCTGGGAGAAT
CACGACCCGACCCAAGGTATGCGCCAGGGGAACGACCATGGCACTCAGTACCGCTCGGCC
ATCTACCCGACCTCTGCCAAGCAAATGGAGGCAGCCCTGAGCTCCAAAGAGAACTACCAA
AAGGTTCTTTCAGAGCACGGCTTCGGCCCCATCACTACCGACATCCGGGAGGGACAGACT
TTCTACTATGCGGAAGACTACCACCAGCAGTACCTGAGCAAGAACCCCAATGGCTACTGC
GGCCTTGGGGGCACCGGCGTGTCCTGCCCAGTGGGTATTAAAAAATAA

# Drug_Target_15_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_15_General_References:
10452521	Kuschel L, Hansel A, Schonherr R, Weissbach H, Brot N, Hoshi T, Heinemann SH: Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA). FEBS Lett. 1999 Jul 30;456(1):17-21.

# Drug_Target_15_HGNC_ID:
HGNC:7377

# Drug_Target_15_HPRD_ID:
03152

# Drug_Target_15_ID:
191

# Drug_Target_15_Locus:
8p23.1

# Drug_Target_15_Molecular_Weight:
26133

# Drug_Target_15_Name:
Peptide methionine sulfoxide reductase

# Drug_Target_15_Number_of_Residues:
235

# Drug_Target_15_PDB_ID:
Not Available

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF01625	PMSR

# Drug_Target_15_Protein_Sequence:
>Peptide methionine sulfoxide reductase
MLSATRRACQLLLLHSLFPVPRMGNSASNIVSPQEALPGRKEQTPVAAKHHVNGNRTVEP
FPEGTQMAVFGMGCFWGAERKFWVLKGVYSTQVGFAGGYTSNPTYKEVCSEKTGHAEVVR
VVYQPEHMSFEELLKVFWENHDPTQGMRQGNDHGTQYRSAIYPTSAKQMEAALSSKENYQ
KVLSEHGFGPITTDIREGQTFYYAEDYHQQYLSKNPNGYCGLGGTGVSCPVGIKK

# Drug_Target_15_Reaction:
(1) peptide-L-methionine + thioredoxin disulfide + H2O = peptide-L-methionine (S)-S-oxide + thioredoxin

# Drug_Target_15_Signals:
None

# Drug_Target_15_Specific_Function:
Has an important function as a repair enzyme for proteins that have been inactivated by oxidation. Catalyzes the reversible oxidation-reduction of methionine sulfoxide in proteins to methionine

# Drug_Target_15_SwissProt_ID:
Q9UJ68

# Drug_Target_15_SwissProt_Name:
MSRA_HUMAN

# Drug_Target_15_Synonyms:
EC 1.8.4.11
PMSR
Peptide Met(O
Peptide-methionine (S)-S-oxide reductase
Protein- methionine-S-oxide reductase

# Drug_Target_15_Theoretical_pI:
8.21

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
Not Available

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
AJ006085

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
torD

# Drug_Target_16_Gene_Sequence:
>630 bp
ATGAGTCAAGTCGATATCAACCACGCCAGAGCCTTGGTTTATCAGCTGTTATCATCACTG
TTTGCCCGCGAAGTTGACGAGCAAAGACTTAAAGAACTCACCAGCGAAGCGGCGCAGCAA
TTTTGGGAACAGCTTAGCCTAGAAGCTAATTTCACTCAGTCAGTGGATAAAATTCGCAGC
ACGCTCAATGGGATAAAAGATGATGAGGCGTTACTCGAACTCGCGGCGGATTACTGCGGC
TTATTTCTCGTTGGCACCAAACACAGCGCTTCACCCTATGCTAGCCTGTATTTAAGTGGC
GAAGATGAACCTCTGCTATTTGGTGAGCAACATCAGCAGATGAGTGAATTTTTACACCAG
AGCAAACTGCAAGTGCAGAGTCATTTCCCTGAGCCCGCCGACCATTTGGCCGTAATGCTC
GCCTATATGGCGCACTTATTTTGTCACAGTGAAAACAGTGTCCAATTAAGCTTTTTGCAA
ACCTGCTTCAACTCTTGGTTAGCAAAATTTATTAACCACCTCACTCAATGCAACAAAAAC
GGTTTTTATAGTGCCGTTGCCACACTCACCTTAGCGTGGGTTAAGCAAGATATCGCACAG
CTTGAACCCGCTGTGGCGATAATTAGCTAA

# Drug_Target_16_General_Function:
Not Available

# Drug_Target_16_General_References:
12192070	Tranier S, Mortier-Barriere I, Ilbert M, Birck C, Iobbi-Nivol C, Mejean V, Samama JP: Characterization and multiple molecular forms of TorD from Shewanella massilia, the putative chaperone of the molybdoenzyme TorA. Protein Sci. 2002 Sep;11(9):2148-57.
12575936	Tranier S, Iobbi-Nivol C, Birck C, Ilbert M, Mortier-Barriere I, Mejean V, Samama JP: A novel protein fold and extreme domain swapping in the dimeric TorD chaperone from Shewanella massilia. Structure. 2003 Feb;11(2):165-74.
9813127	Dos Santos JP, Iobbi-Nivol C, Couillault C, Giordano G, Mejean V: Molecular analysis of the trimethylamine N-oxide (TMAO) reductase respiratory system from a Shewanella species. J Mol Biol. 1998 Nov 27;284(2):421-33.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
5675

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
23555

# Drug_Target_16_Name:
Chaperone protein torD

# Drug_Target_16_Number_of_Residues:
209

# Drug_Target_16_PDB_ID:
1N1C

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF06192	TorD

# Drug_Target_16_Protein_Sequence:
>Chaperone protein torD
MSQVDINHARALVYQLLSSLFAREVDEQRLKELTSEAAQQFWEQLSLEANFTQSVDKIRS
TLNGIKDDEALLELAADYCGLFLVGTKHSASPYASLYLSGEDEPLLFGEQHQQMSEFLHQ
SKLQVQSHFPEPADHLAVMLAYMAHLFCHSENSVQLSFLQTCFNSWLAKFINHLTQCNKN
GFYSAVATLTLAWVKQDIAQLEPAVAIIS

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
None

# Drug_Target_16_Specific_Function:
Involved in the biogenesis of torA. Acts on torA before the insertion of the molybdenum cofactor and, as a result, probably favors a conformation of the apoenzyme that is competent for acquiring the cofactor

# Drug_Target_16_SwissProt_ID:
O87949

# Drug_Target_16_SwissProt_Name:
TORD_SHEMA

# Drug_Target_16_Synonyms:
Not Available

# Drug_Target_16_Theoretical_pI:
4.85

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Cytoplasm

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
Not Available

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
AXIN1

# Drug_Target_17_GenBank_ID_Gene:
AE006463

# Drug_Target_17_GenBank_ID_Protein:
Not Available

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
AXIN1

# Drug_Target_17_Gene_Sequence:
>2589 bp
ATGAATATCCAAGAGCAGGGTTTCCCCTTGGACCTCGGAGCAAGTTTCACCGAAGATGCT
CCCCGACCCCCAGTGCCTGGTGAGGAGGGAGAACTGGTGTCCACAGACCCGAGGCCCGCC
AGCTACAGTTTCTGCTCCGGGAAAGGTGTTGGCATTAAAGGTGAGACTTCGACGGCCACT
CCGAGGCGCTCGGATCTGGACCTGGGGTATGAGCCTGAGGGCAGTGCCTCCCCCACCCCA
CCATACTTGAAGTGGGCTGAGTCACTGCATTCCCTGCTGGATGACCAAGATGGGATAAGC
CTGTTCAGGACTTTCCTGAAGCAGGAGGGCTGTGCCGACTTGCTGGACTTCTGGTTTGCC
TGCACTGGCTTCAGGAAGCTGGAGCCCTGTGACTCGAACGAGGAGAAGAGGCTGAAGCTG
GCGAGAGCCATCTACCGAAAGTACATTCTTGATAACAATGGCATCGTGTCCCGGCAGACC
AAGCCAGCCACCAAGAGCTTCATAAAGGGCTGCATCATGAAGCAGCTGATCGATCCTGCC
ATGTTTGACCAGGCCCAGACCGAAATCCAGGCCACTATGGAGGAAAACACCTATCCCTCC
TTCCTTAAGTCTGATATTTATTTGGAATATACGAGGACAGGCTCGGAGAGCCCCAAAGTC
TGTAGTGACCAGAGCTCTGGGTCAGGGACAGGGAAGGGCATATCTGGATACCTGCCGACC
TTAAATGAAGATGAGGAATGGAAGTGTGACCAGGACATGGATGAGGACGATGGCAGAGAC
GCTGCTCCCCCCGGAAGACTCCCTCAGAAGCTGCTCCTGGAGACAGCTGCCCCGAGGGTC
TCCTCCAGTAGACGGTACAGCGAAGGCAGAGAGTTCAGGTATGGATCCTGGCGGGAGCCA
GTCAACCCCTATTATGTCAATGCCGGCTATGCCCTGGCCCCAGCCACCAGTGCCAACGAC
AGCGAGCAGCAGAGCCTGTCCAGCGATGCAGACACCCTGTCCCTCACGGACAGCAGCGTG
GATGGGATCCCCCCATACAGGATCCGTAAGCAGCACCGCAGGGAGATGCAGGAGAGCGTG
CAGGTCAATGGGCGGGTGCCCCTACCTCACATTCCCCGCACGTACCGGGTGCCGAAGGAG
GTCCGCGTGGAGCCTCAGAAGTTCGCGGAGGAGCTCATCCACCGCCTGGAGGCTGTGCAG
CGCACGCGGGAGGCCGAGGAGAAGCTGGAGGAGCGGCTGAAGCGCGTGCGCATGGAGGAG
GAAGGTGAGGACGGCGATCCATCGTCAGGGCCCCCAGGGCCGTGTCACAAGCTGCCTCCC
GCCCCCGCTTGGCACCACTTCCCGCCCCGCTGTGTGGACATGGGCTGTGCCGGGCTCCGG
GATGCACACGAGGAGAACCCTGAGAGCATCCTGGACGAGCACGTACAGCGTGTGCTGAGG
ACACCTGGCCGCCAGTCGCCTGGGCCTGGCCATCGCTCCCCGGACAGTGGGCACGTGGCC
AAGATGCCAGTGGCACTGGGGGGTGCCGCCTCGGGGCACGGGAAGCACGTACCCAAGTCA
GGGGCGAAGCTGGACGCGGCCGGCCTGCACCACCACCGACACGTCCACCACCACGTCCAC
CACAGCACAGCCCGGCCCAAGGAGCAGGTGGAGGCCGAGGCCACCCGCAGGGCCCAGAGC
AGCTTCGCCTGGGGCCTGGAACCACACAGCCATGGGGCAAGGTCCCGAGGCTACTCAGAG
AGTGTTGGCGCTGCCCCCAACGCCAGTGATGGCCTCGCCCACAGTGGGAAGGTGGGCGTG
GCGTGCAAAAGAAATGCCAAGAAGGCTGAGTCGGGGAAGAGCGCCAGCACCGAGGTGCCA
GGTGCCTCGGAGGATGCGGAGAAGAACCAGAAAATCATGCAGTGGATCATTGAGGGGGAA
AAGGAGATCAGCAGGCACCGCAGGACCGGCCACGGGTCTTCGGGGACGAGGAAGCCACAG
CCCCATGAGAACTCCAGACCCTTGTCCCTTGAGCACCCCTGGGCCGGCCCTCAGCTCCGG
ACCTCCGTGCAGCCCTCCCACCTCTTCATCCAAGACCCCACCATGCCACCCCACCCAGCT
CCCAACCCCCTAACCCAGCTGGAGGAGGCGCGCCGACGTCTGGAGGAGGAAGAAAAGAGA
GCCAGCCGAGCACCCTCCAAGCAGAGGTATGTGCAGGAGGTTATGCGGCGGGGACGCGCC
TGCGTCAGGCCAGCGTGCGCGCCGGTGCTGCACGTGGTACCAGCCGTGTCGGACATGGAG
CTCTCCGAGACAGAGACAAGATCGCAGAGGAAGGTGGGCGGCGGGAGTGCCCAGCCGTGT
GACAGCATCGTTGTGGCGTACTACTTCTGCGGGGAACCCATCCCCTACCGCACCCTGGTG
AGGGGCCGCGCTGTCACCCTGGGCCAGTTCAAGGAGCTGCTGACCAAAAAGGGCAGCTAC
AGATACTACTTCAAGAAAGTGAGCGACGAGTTTGACTGTGGGGTGGTGTTTGAGGAGGTT
CGAGAGGACGAGGCCGTCCTGCCCGTCTTTGAGGAGAAGATCATCGGCAAAGTGGAGAAG
GTGGACTGA

# Drug_Target_17_General_Function:
Involved in signal transducer activity

# Drug_Target_17_General_References:
10700176	Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet. 2000 Mar;24(3):245-50.
10811618	Spink KE, Polakis P, Weis WI: Structural basis of the Axin-adenomatous polyposis coli interaction. EMBO J. 2000 May 15;19(10):2270-9.
11157797	Daniels RJ, Peden JF, Lloyd C, Horsley SW, Clark K, Tufarelli C, Kearney L, Buckle VJ, Doggett NA, Flint J, Higgs DR: Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet. 2001 Feb 15;10(4):339-52.
12101426	Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W: Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002 Jul 18;21(31):4863-71.
9230313	Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F: The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell. 1997 Jul 11;90(1):181-92.

# Drug_Target_17_HGNC_ID:
HGNC:903

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
5676

# Drug_Target_17_Locus:
16p13.3

# Drug_Target_17_Molecular_Weight:
95636

# Drug_Target_17_Name:
Axin-1

# Drug_Target_17_Number_of_Residues:
862

# Drug_Target_17_PDB_ID:
1DK8

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF00615	RGS
PF00778	DIX
PF08833	Axin_b-cat_bind

# Drug_Target_17_Protein_Sequence:
>Axin-1
MNIQEQGFPLDLGASFTEDAPRPPVPGEEGELVSTDPRPASYSFCSGKGVGIKGETSTAT
PRRSDLDLGYEPEGSASPTPPYLKWAESLHSLLDDQDGISLFRTFLKQEGCADLLDFWFA
CTGFRKLEPCDSNEEKRLKLARAIYRKYILDNNGIVSRQTKPATKSFIKGCIMKQLIDPA
MFDQAQTEIQATMEENTYPSFLKSDIYLEYTRTGSESPKVCSDQSSGSGTGKGISGYLPT
LNEDEEWKCDQDMDEDDGRDAAPPGRLPQKLLLETAAPRVSSSRRYSEGREFRYGSWREP
VNPYYVNAGYALAPATSANDSEQQSLSSDADTLSLTDSSVDGIPPYRIRKQHRREMQESV
QVNGRVPLPHIPRTYRVPKEVRVEPQKFAEELIHRLEAVQRTREAEEKLEERLKRVRMEE
EGEDGDPSSGPPGPCHKLPPAPAWHHFPPRCVDMGCAGLRDAHEENPESILDEHVQRVLR
TPGRQSPGPGHRSPDSGHVAKMPVALGGAASGHGKHVPKSGAKLDAAGLHHHRHVHHHVH
HSTARPKEQVEAEATRRAQSSFAWGLEPHSHGARSRGYSESVGAAPNASDGLAHSGKVGV
ACKRNAKKAESGKSASTEVPGASEDAEKNQKIMQWIIEGEKEISRHRRTGHGSSGTRKPQ
PHENSRPLSLEHPWAGPQLRTSVQPSHLFIQDPTMPPHPAPNPLTQLEEARRRLEEEEKR
ASRAPSKQRYVQEVMRRGRACVRPACAPVLHVVPAVSDMELSETETRSQRKVGGGSAQPC
DSIVVAYYFCGEPIPYRTLVRGRAVTLGQFKELLTKKGSYRYYFKKVSDEFDCGVVFEEV
REDEAVLPVFEEKIIGKVEKVD

# Drug_Target_17_Reaction:
Not Available

# Drug_Target_17_Signals:
None

# Drug_Target_17_Specific_Function:
Inhibitor of the Wnt signaling pathway. Down-regulates beta-catenin. Probably facilitate the phosphorylation of beta- catenin and APC by GSK3B. Likely to function as a tumor suppressor. Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation. Wild-type axin 1 can induce apoptosis in hepatocellular and colorectal cancer cells. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7

# Drug_Target_17_SwissProt_ID:
O15169

# Drug_Target_17_SwissProt_Name:
AXN1_HUMAN

# Drug_Target_17_Synonyms:
Axis inhibition protein 1
hAxin

# Drug_Target_17_Theoretical_pI:
6.95

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
PPIB

# Drug_Target_18_GenBank_ID_Gene:
M60857

# Drug_Target_18_GenBank_ID_Protein:
181335

# Drug_Target_18_GeneCard_ID:
PPIB

# Drug_Target_18_Gene_Name:
PPIB

# Drug_Target_18_Gene_Sequence:
>627 bp
ATGAAGGTGCTCCTTGCCGCCGCCCTCATCGCGGGGTCCGTCTTCTTCCTGCTGCTGCCG
GGACCTTCTGCGGCCGATGAGAAGAAGAAGGGGCCCAAAGTCACCGTCAAGGTGTATTTT
GACCTACGAATTGGAGATGAAGATGTAGGCCGGGTGATCTTTGGTCTCTTCGGAAAGACT
GTTCCAAAAACAGTGGATAATTTTGTGGCCTTAGCTACAGGAGAGAAAGGATTTGGCTAC
AAAAACAGCAAATTCCATCGTGTAATCAAGGACTTCATGATCCAGGGCGGAGACTTCACC
AGGGGAGATGGCACAGGAGGAAAGAGCATCTACGGTGAGCGCTTCCCCGATGAGAACTTC
AAACTGAAGCACTACGGGCCTGGCTGGGTCAGCATGGCCAACGCAGGCAAAGACACCAAC
GGCTCCCAGTTCTTCATCACGACAGTCAAGACAGCCTGGCTAGATGGCAAGCATGTGGTG
TTTGGCAAAGTTCTAGAGGGCATGGAGGTGGTGCGGAAGGTGGAGAGCACCAAGACAGAC
AGCCGGGATAAACCCCTGAAGGATGTGATCATCGCAGACTGCGGCAAGATCGAGGTGGAG
AAGCCCTTTGCCATCGCCAAGGAGTAG

# Drug_Target_18_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_18_General_References:
1286667	Rasmussen HH, van Damme J, Puype M, Gesser B, Celis JE, Vandekerckhove J: Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes. Electrophoresis. 1992 Dec;13(12):960-9.
1530944	Arber S, Krause KH, Caroni P: s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J Cell Biol. 1992 Jan;116(1):113-25.
1710767	Hasel KW, Glass JR, Godbout M, Sutcliffe JG: An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol. 1991 Jul;11(7):3484-91.
2000394	Price ER, Zydowsky LD, Jin MJ, Baker CH, McKeon FD, Walsh CT: Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1903-7.
2040592	Spik G, Haendler B, Delmas O, Mariller C, Chamoux M, Maes P, Tartar A, Montreuil J, Stedman K, Kocher HP, et al.: A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem. 1991 Jun 15;266(17):10735-8.
8197205	Mikol V, Kallen J, Walkinshaw MD: X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5183-6.

# Drug_Target_18_HGNC_ID:
HGNC:9255

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
4084

# Drug_Target_18_Locus:
15q21-q22

# Drug_Target_18_Molecular_Weight:
22743

# Drug_Target_18_Name:
Peptidyl-prolyl cis-trans isomerase B

# Drug_Target_18_Number_of_Residues:
208

# Drug_Target_18_PDB_ID:
1CYN

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF00160	Pro_isomerase

# Drug_Target_18_Protein_Sequence:
>Peptidyl-prolyl cis-trans isomerase B
MKVLLAAALIAGSVFFLLLPGPSAADEKKKGPKVTVKVYFDLRIGDEDVGRVIFGLFGKT
VPKTVDNFVALATGEKGFGYKNSKFHRVIKDFMIQGGDFTRGDGTGGKSIYGERFPDENF
KLKHYGPGWVSMANAGKDTNGSQFFITTVKTAWLDGKHVVFGKVLEGMEVVRKVESTKTD
SRDKPLKDVIIADCGKIEVEKPFAIAKE

# Drug_Target_18_Reaction:
peptidylproline (omega=180) = peptidylproline (omega=0)

# Drug_Target_18_Signals:
1-25

# Drug_Target_18_Specific_Function:
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides

# Drug_Target_18_SwissProt_ID:
P23284

# Drug_Target_18_SwissProt_Name:
PPIB_HUMAN

# Drug_Target_18_Synonyms:
CYP-S1
Cyclophilin B
EC 5.2.1.8
PPIase
Peptidyl-prolyl cis-trans isomerase B precursor
Rotamase
S-cyclophilin
SCYLP

# Drug_Target_18_Theoretical_pI:
9.97

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Secreted protein

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
Not Available

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AJ011781

# Drug_Target_19_GenBank_ID_Protein:
Not Available

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
ams

# Drug_Target_19_Gene_Sequence:
>1911 bp
ATGTTGACCCCCACGCAGCAAGTCGGTTTGATTTTACAGTACCTCAAAACACGCATCTTG
GACATCTACACGCCCGAACAGCGCGCCGGCATCGAAAAATCCGAAGACTGGCGGCAGTTT
TCGCGCCGCATGGATACGCATTTCCCCAAACTGATGAACGAACTCGACAGCGTGTACGGC
AACAACGAAGCCCTGCTGCCTATGCTGGAAATGCTGCTGGCGCAGGCATGGCAAAGCTAT
TCCCAACGCAACTCATCCTTAAAAGATATCGATATCGCGCGCGAAAACAACCCCGATTGG
ATTTTGTCCAACAAACAAGTCGGCGGCGTGTGCTACGTTGATTTGTTTGCCGGCGATTTG
AAGGGCTTGAAAGATAAAATTCCTTATTTTCAAGAGCTTGGTTTGACTTATCTGCACCTG
ATGCCGCTGTTTAAATGCCCTGAAGGCAAAAGCGACGGCGGCTATGCGGTCAGCAGCTAC
CGCGATGTCAATCCGGCACTGGGCACAATAGGCGACTTGCGCGAAGTCATTGCTGCGCTG
CACGAAGCCGGCATTTCCGCCGTCGTCGATTTTATCTTCAACCACACCTCCAACGAACAC
GAATGGGCGCAACGCTGCGCCGCCGGCGACCCGCTTTTCGACAATTTCTACTATATTTTC
CCCGACCGCCGGATGCCCGACCAATACGACCGCACCCTGCGCGAAATCTTCCCCGACCAG
CACCCGGGCGGCTTCTCGCAACTGGAAGACGGACGCTGGGTGTGGACGACCTTCAATTCC
TTCCAATGGGACTTGAATTACAGCAACCCGTGGGTATTCCGCGCAATGGCGGGCGAAATG
CTGTTCCTTGCCAACTTGGGCGTTGACATCCTGCGTATGGATGCGGTTGCCTTTATTTGG
AAACAAATGGGGACAAGCTGCGAAAACCTGCCGCAGGCGCACGCCCTCATCCGCGCGTTC
AATGCCGTTATGCGTATTGCCGCGCCCGCCGTGTTCTTCAAATCCGAAGCCATCGTCCAC
CCCGACCAAGTCGTCCAATACATCGGGCAGGACGAATGCCAAATCGGTTACAACCCCCTG
CAAATGGCATTGTTGTGGAACACCCTTGCCACGCGCGAAGTCAACCTGCTCCATCAGGCG
CTGACCTACCGCCACAACCTGCCCGAGCATACCGCCTGGGTCAACTACGTCCGCAGCCAC
GACGACATCGGCTGGACGTTTGCCGATGAAGACGCGGCATATCTGGGCATAAGCGGCTAC
GACCACCGCCAATTCCTCAACCGCTTCTTCGTCAACCGTTTCGACGGCAGCTTCGCTCGT
GGCGTACCGTTCCAATACAACCCAAGCACAGGCGACTGCCGTGTCAGTGGTACAGCCGCG
GCATTGGTCGGCTTGGCGCAAGACGATCCCCACGCCGTTGACCGCATCAAACTCTTGTAC
AGCATTGCTTTGAGTACCGGCGGTCTGCCGCTGATTTACCTAGGCGACGAAGTGGGTACG
CTCAATGACGACGACTGGTCGCAAGACAGCAATAAGAGCGACGACAGCCGTTGGGCGCAC
CGTCCGCGCTACAACGAAGCCCTGTACGCGCAACGCAACGATCCGTCGACCGCAGCCGGG
CAAATCTATCAGGGCTTGCGCCATATGATTGCCGTCCGCCAAAGCAATCCGCGCTTCGAC
GGCGGCAGGCTGGTTACATTCAACACCAACAACAAGCACATCATCGGCTACATCCGCAAC
AATGCGCTTTTGGCATTCGGTAACTTCAGCGAATATCCGCAAACCGTTACCGCGCATACC
CTGCAAGCCATGCCCTTCAAGGCGCACGACCTCATCGGTGGCAAAACTGTCAGCCTGAAT
CAGGATTTGACGCTTCAGCCCTATCAGGTCATGTGGCTCGAAATCGCCTGA

# Drug_Target_19_General_Function:
Involved in catalytic activity

# Drug_Target_19_General_References:
10767427	Potocki de Montalk G, Remaud-Simeon M, Willemot RM, Sarcabal P, Planchot V, Monsan P: Amylosucrase from Neisseria polysaccharea: novel catalytic properties. FEBS Lett. 2000 Apr 14;471(2-3):219-23.
10828446	Sarcabal P, Remaud-Simeon M, Willemot R, Potocki de Montalk G, Svensson B, Monsan P: Identification of key amino acid residues in Neisseria polysaccharea amylosucrase. FEBS Lett. 2000 May 26;474(1):33-7.
12517860	Zhu P, Tsang RS, Tsai CM: Nonencapsulated Neisseria meningitidis strain produces amylopectin from sucrose: altering the concept for differentiation between N. meningitidis and N. polysaccharea. J Clin Microbiol. 2003 Jan;41(1):273-8.
9882648	De Montalk GP, Remaud-Simeon M, Willemot RM, Planchot V, Monsan P: Sequence analysis of the gene encoding amylosucrase from Neisseria polysaccharea and characterization of the recombinant enzyme. J Bacteriol. 1999 Jan;181(2):375-81.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
4811

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
72344

# Drug_Target_19_Name:
Amylosucrase

# Drug_Target_19_Number_of_Residues:
636

# Drug_Target_19_PDB_ID:
1MW3

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF00128	Alpha-amylase

# Drug_Target_19_Protein_Sequence:
>Amylosucrase
MLTPTQQVGLILQYLKTRILDIYTPEQRAGIEKSEDWRQFSRRMDTHFPKLMNELDSVYG
NNEALLPMLEMLLAQAWQSYSQRNSSLKDIDIARENNPDWILSNKQVGGVCYVDLFAGDL
KGLKDKIPYFQELGLTYLHLMPLFKCPEGKSDGGYAVSSYRDVNPALGTIGDLREVIAAL
HEAGISAVVDFIFNHTSNEHEWAQRCAAGDPLFDNFYYIFPDRRMPDQYDRTLREIFPDQ
HPGGFSQLEDGRWVWTTFNSFQWDLNYSNPWVFRAMAGEMLFLANLGVDILRMDAVAFIW
KQMGTSCENLPQAHALIRAFNAVMRIAAPAVFFKSEAIVHPDQVVQYIGQDECQIGYNPL
QMALLWNTLATREVNLLHQALTYRHNLPEHTAWVNYVRSHDDIGWTFADEDAAYLGISGY
DHRQFLNRFFVNRFDGSFARGVPFQYNPSTGDCRVSGTAAALVGLAQDDPHAVDRIKLLY
SIALSTGGLPLIYLGDEVGTLNDDDWSQDSNKSDDSRWAHRPRYNEALYAQRNDPSTAAG
QIYQGLRHMIAVRQSNPRFDGGRLVTFNTNNKHIIGYIRNNALLAFGNFSEYPQTVTAHT
LQAMPFKAHDLIGGKTVSLNQDLTLQPYQVMWLEIA

# Drug_Target_19_Reaction:
Not Available

# Drug_Target_19_Signals:
None

# Drug_Target_19_Specific_Function:
Catalyzes the synthesis of alpha-glucan from sucrose. Catalyzes, in addition, sucrose hydrolysis, maltose and maltotriose synthesis by successive transfers of the glucosyl moiety of sucrose onto the released glucose, and finally turanose and trehalulose synthesis, these two sucrose isomers being obtained by glucosyl transfer onto fructose

# Drug_Target_19_SwissProt_ID:
Q9ZEU2

# Drug_Target_19_SwissProt_Name:
AMYS_NEIPO

# Drug_Target_19_Synonyms:
EC 2.4.1.4

# Drug_Target_19_Theoretical_pI:
5.55

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M36471

# Drug_Target_1_GenBank_ID_Protein:
143284

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
paiA

# Drug_Target_1_Gene_Sequence:
>519 bp
ATGAGTGTAAAAATGAAAAAATGCAGCCGGGAAGATTTACAAACACTTCAACAATTGAGT
ATTGAAACATTCAATGACATTTTTAAAGAACAGAACTCACCTGAAAATATGAAAGCCTAT
TTAGAAAGCGCATTTAACACTGAGCAGCTGGAAAAAGAGTTATCTAATATGTCTTCGCAA
TTCTTTTTTATTTACTTTGATCATGAAATCGCTGGATATGTAAAGGTCAATATCGATGAT
GCTCAGTCTGAAGAAATGGGTGCTGAATCACTTGAAATCGAGAGAATTTATATAAAGAAC
AGCTTTCAAAAACATGGGCTTGGCAAACATCTGCTGAATAAAGCGATAGAAATTGCGCTG
GAACGTAATAAAAAGAACATTTGGCTAGGTGTGTGGGAAAAAAATGAAAATGCCATTGCC
TTTTATAAGAAAATGGGGTTTGTTCAGACCGGCGCCCACTCATTTTATATGGGTGATGAA
GAACAAACGGATTTAATCATGGCTAAAACACTCATATAA

# Drug_Target_1_General_Function:
Transcription

# Drug_Target_1_General_References:
2108124	Honjo M, Nakayama A, Fukazawa K, Kawamura K, Ando K, Hori M, Furutani Y: A novel Bacillus subtilis gene involved in negative control of sporulation and degradative-enzyme production. J Bacteriol. 1990 Apr;172(4):1783-90.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3125

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
20015

# Drug_Target_1_Name:
Protease synthase and sporulation negative regulatory protein PAI 1

# Drug_Target_1_Number_of_Residues:
172

# Drug_Target_1_PDB_ID:
1TIQ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00583	Acetyltransf_1

# Drug_Target_1_Protein_Sequence:
>Protease synthase and sporulation negative regulatory protein PAI 1
MSVKMKKCSREDLQTLQQLSIETFNDTFKEQNSPENMKAYLESAFNTEQLEKELSNMSSQ
FFFIYFDHEIAGYVKVNIDDAQSEEMGAESLEIERIYIKNSFQKHGLGKHLLNKAIEIAL
ERNKKNIWLGVWEKNENAIAFYKKMGFVQTGAHSFYMGDEEQTDLIMAKTLI

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Possesses N1-acetyltransferase activity toward polyamine substrates including spermidine and spermine. capable of acetylating both spermidine and spermine. In this way it may function in regulating intracellular polyamine concentrations and/or binding capabilities. In addition to preventing toxicity due to polyamine excess, this function may also serve to regulate expression of certain bacterial gene products such as those involved in sporulation

# Drug_Target_1_SwissProt_ID:
P21340

# Drug_Target_1_SwissProt_Name:
PAIA_BACSU

# Drug_Target_1_Synonyms:
EC 2.3.1.-

# Drug_Target_1_Theoretical_pI:
4.95

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Cytoplasm

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
J01710

# Drug_Target_20_GenBank_ID_Protein:
147987

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
thyA

# Drug_Target_20_Gene_Sequence:
>795 bp
ATGAAACAGTATTTAGAACTGATGCAAAAAGTGCTCGACGAAGGCACACAGAAAAACGAC
CGTACCGGAACCGGAACGCTTTCCATTTTTGGTCATCAGATGCGTTTTAACCTGCAAGAT
GGATTCCCGCTGGTGACAACTAAACGTTGCCACCTGCGTTCCATCATCCATGAACTGCTG
TGGTTTCTGCAGGGCGACACTAACATTGCTTATCTACACGAAAACAATGTCACCATCTGG
GACGAATGGGCCGATGAAAACGGCGACCTCGGGCCAGTGTATGGTAAACAGTGGCGCGCC
TGGCCAACGCCAGATGGTCGTCATATTGACCAGATCACTACGGTACTGAACCAGCTGAAA
AACGACCCGGATTCGCGCCGCATTATTGTTTCAGCGTGGAACGTAGGCGAACTGGATAAA
ATGGCGCTGGCACCGTGCCATGCATTCTTCCAGTTCTATGTGGCAGACGGCAAACTCTCT
TGCCAGCTTTATCAGCGCTCCTGTGACGTCTTCCTCGGCCTGCCGTTCAACATTGCCAGC
TACGCGTTATTGGTGCATATGATGGCGCAGCAGTGCGATCTGGAAGTGGGTGATTTTGTC
TGGACCGGTGGCGACACGCATCTGTACAGCAACCATATGGATCAAACTCATCTGCAATTA
AGCCGCGAACCGCGTCCGCTGCCGAAGTTGATTATCAAACGTAAACCCGAATCCATCTTC
GACTACCGTTTCGAAGACTTTGAGATTGAAGGCTACGATCCGCATCCGGGCATTAAAGCG
CCGGTGGCTATCTAA

# Drug_Target_20_General_Function:
Nucleotide transport and metabolism

# Drug_Target_20_General_References:
10944209	Erlanson DA, Braisted AC, Raphael DR, Randal M, Stroud RM, Gordon EM, Wells JA: Site-directed ligand discovery. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72.
1518803	Kim CW, Michaels ML, Miller JH: Amino acid substitution analysis of E. coli thymidylate synthase: the study of a highly conserved region at the N-terminus. Proteins. 1992 Aug;13(4):352-63.
2128651	Perry KM, Fauman EB, Finer-Moore JS, Montfort WR, Maley GF, Maley F, Stroud RM: Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. Proteins. 1990;8(4):315-33.
2223754	Montfort WR, Perry KM, Fauman EB, Finer-Moore JS, Maley GF, Hardy L, Maley F, Stroud RM: Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry. 1990 Jul 31;29(30):6964-77.
3520484	Finch PW, Wilson RE, Brown K, Hickson ID, Tomkinson AE, Emmerson PT: Complete nucleotide sequence of the Escherichia coli recC gene and of the thyA-recC intergenic region. Nucleic Acids Res. 1986 Jun 11;14(11):4437-51.
6308660	Belfort M, Maley G, Pedersen-Lane J, Maley F: Primary structure of the Escherichia coli thyA gene and its thymidylate synthase product. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4914-8.
7708505	Voeller DM, Changchien LM, Maley GF, Maley F, Takechi T, Turner RE, Montfort WR, Allegra CJ, Chu E: Characterization of a specific interaction between Escherichia coli thymidylate synthase and Escherichia coli thymidylate synthase mRNA. Nucleic Acids Res. 1995 Mar 11;23(5):869-75.
8312270	Fauman EB, Rutenber EE, Maley GF, Maley F, Stroud RM: Water-mediated substrate/product discrimination: the product complex of thymidylate synthase at 1.83 A. Biochemistry. 1994 Feb 15;33(6):1502-11.
8973201	Sage CR, Rutenber EE, Stout TJ, Stroud RM: An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E58Q. Biochemistry. 1996 Dec 17;35(50):16270-81.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9416600	Strop P, Changchien L, Maley F, Montfort WR: Crystal structures of a marginally active thymidylate synthase mutant, Arg 126-->Glu. Protein Sci. 1997 Dec;6(12):2504-11.
9826509	Reyes CL, Sage CR, Rutenber EE, Nissen RM, Finer-Moore JS, Stroud RM: Inactivity of N229A thymidylate synthase due to water-mediated effects: isolating a late stage in methyl transfer. J Mol Biol. 1998 Dec 4;284(3):699-712.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
2626

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
30480

# Drug_Target_20_Name:
Thymidylate synthase

# Drug_Target_20_Number_of_Residues:
264

# Drug_Target_20_PDB_ID:
2KCE

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF00303	Thymidylat_synt

# Drug_Target_20_Protein_Sequence:
>Thymidylate synthase
MKQYLELMQKVLDEGTQKNDRTGTGTLSIFGHQMRFNLQDGFPLVTTKRCHLRSIIHELL
WFLQGDTNIAYLHENNVTIWDEWADENGDLGPVYGKQWRAWPTPDGRHIDQITTVLNQLK
NDPDSRRIIVSAWNVGELDKMALAPCHAFFQFYVADGKLSCQLYQRSCDVFLGLPFNIAS
YALLVHMMAQQCDLEVGDFVWTGGDTHLYSNHMDQTHLQLSREPRPLPKLIIKRKPESIF
DYRFEDFEIEGYDPHPGIKAPVAI

# Drug_Target_20_Reaction:
5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP

# Drug_Target_20_Signals:
None

# Drug_Target_20_Specific_Function:
Provides the sole de novo source of dTMP for DNA biosynthesis. This protein also binds to its mRNA thus repressing its own translation

# Drug_Target_20_SwissProt_ID:
P0A884

# Drug_Target_20_SwissProt_Name:
TYSY_ECOLI

# Drug_Target_20_Synonyms:
EC 2.1.1.45
TS
TSase

# Drug_Target_20_Theoretical_pI:
5.94

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Not Available

# Drug_Target_21_Chromosome_Location:
1

# Drug_Target_21_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
M10036

# Drug_Target_21_GenBank_ID_Protein:
339841

# Drug_Target_21_GeneCard_ID:
TPI1

# Drug_Target_21_Gene_Name:
TPI1

# Drug_Target_21_Gene_Sequence:
>750 bp
GCGACACTGACCTTCAGCGCCTCGGCTCGGCCATGGCGCCCTCCAGGAAGTTCTTCGTTG
GGGGAAACTGGAAGATGAACGGGCGGAAGCAGAGTCTGGGGGAGCTCATCGGCACTCTGA
ACGCGGCCAAGGTGCCGGCCGACACCGAGGTGGTTTGTGCTCCCCCTACTGCCTATATCG
ACTTCGCCCGGCAGAAGCTAGATCCCAAGATTGCTGTGGCTGCGCAGAACTGCTACAAAG
TGACTAATGGGGCTTTTACTGGGGAGATCAGCCCTGGCATGATCAAAGACTGCGGAGCCA
CGTGGGTGGTCCTGGGACACTCAGAGAGAAGGCATGTCTTTGGGGAGTCAGATGAGCTGA
TTGGGCAGAAAGTGGCCCATGCTCTGGCAGAGGGACTCGGAGTAATCGCCTGCATTGGGG
AGAAGCTAGATGAAAGGGAAGCTGGCATCACTGAGAAGGTTGTTTTCGAGCAGACAAAGG
TCATCGCAGATAACGTGAAGGACTGGAGCAAGGTCGTCCTCGCCTATGAGCCTGTGTGGG
CCATTGGTACTGGCAAGACTGCAACACCCCAACAGGCCCAGGAAGTACACGAGAAGCTCC
GAGGATGGCTGAAGTCCAACGTCTCTGATGCGGTGGCTCAGAGCACCCGTATCATTTATG
GAGGCTCTGTGACTGGGGCAACCTGCAAGGAGCTGGCCAGCCAGCCTGATGTGGATGGCT
TCCTTGTGGGTGGTGCTTCCCTCAAGCCCG

# Drug_Target_21_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_21_General_References:
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
2579079	Maquat LE, Chilcote R, Ryan PM: Human triosephosphate isomerase cDNA and protein structure. Studies of triosephosphate isomerase deficiency in man. J Biol Chem. 1985 Mar 25;260(6):3748-53.
2925688	Boyer TG, Krug JR, Maquat LE: Transcriptional regulatory sequences of the housekeeping gene for human triosephosphate isomerase. J Biol Chem. 1989 Mar 25;264(9):5177-87.
4022011	Brown JR, Daar IO, Krug JR, Maquat LE: Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family. Mol Cell Biol. 1985 Jul;5(7):1694-706.
6434534	Lu HS, Yuan PM, Gracy RW: Primary structure of human triosephosphate isomerase. J Biol Chem. 1984 Oct 10;259(19):11958-68.
8723724	Ansari-Lari MA, Muzny DM, Lu J, Lu F, Lilley CE, Spanos S, Malley T, Gibbs RA: A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13. Genome Res. 1996 Apr;6(4):314-26.
9074930	Ansari-Lari MA, Shen Y, Muzny DM, Lee W, Gibbs RA: Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination. Genome Res. 1997 Mar;7(3):268-80.
9150946	Rasmussen RK, Ji H, Eddes JS, Moritz RL, Reid GE, Simpson RJ, Dorow DS: Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2. Electrophoresis. 1997 Mar-Apr;18(3-4):588-98.
9150948	Ji H, Reid GE, Moritz RL, Eddes JS, Burgess AW, Simpson RJ: A two-dimensional gel database of human colon carcinoma proteins. Electrophoresis. 1997 Mar-Apr;18(3-4):605-13.

# Drug_Target_21_HGNC_ID:
GNC:12009

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
6346

# Drug_Target_21_Locus:
12p13

# Drug_Target_21_Molecular_Weight:
26669.3

# Drug_Target_21_Name:
Triosephosphate isomerase

# Drug_Target_21_Number_of_Residues:
249

# Drug_Target_21_PDB_ID:
1HTI

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00121	TIM

# Drug_Target_21_Protein_Sequence:
>Triosephosphate isomerase
MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKI
AVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAE
GLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQ
QAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPE
FVDIINAKQ

# Drug_Target_21_Reaction:
Not Available

# Drug_Target_21_Signals:
None

# Drug_Target_21_Specific_Function:
D-glyceraldehyde 3-phosphate = glycerone phosphate

# Drug_Target_21_SwissProt_ID:
P60174

# Drug_Target_21_SwissProt_Name:
TPIS_HUMAN

# Drug_Target_21_Synonyms:
TIM
Triose-phosphate isomerase

# Drug_Target_21_Theoretical_pI:
6.91

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Cytoplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
GSTZ1

# Drug_Target_22_GenBank_ID_Gene:
AJ001838

# Drug_Target_22_GenBank_ID_Protein:
2832731

# Drug_Target_22_GeneCard_ID:
GSTZ1

# Drug_Target_22_Gene_Name:
GSTZ1

# Drug_Target_22_Gene_Sequence:
>651 bp
ATGCAGGCGGGGAAGCCCATCCTCTATTCCTATTTCCGAAGCTCCTGCTCATGGAGAGTT
CGAATTGCTCTGGCCTTGAAAGGCATCGACTACAAGACGGTGCCCATCAATCTCATAAAG
GATGGGGGCCAACAGTTTTCTAAGGACTTCCAGGCACTGAATCCTATGAAGCAGGTGCCA
ACCCTGAAGATTGATGGAATCACCATTCACCAGTCACTGGCCATCATTGAGTATCTAGAG
GAGACGCGTCCCACTCCGCGACTTCTGCCTCAGGACCCAAAGAAGAGGGCCAGCGTGCGT
ATGATTTCTGACCTCATCGCTGGTGGCATCCAGCCCCTGCAGAACCTGTCTGTCCTGAAG
CAAGTGGGAGAGGAGATGCAGCTGACCTGGGCCCAGAACGCCATCACTTGTGGCTTTAAC
GCCCTGGAGCAGATCCTACAGAGCACAGCGGGCATATACTGTGTAGGAGACGAGGTGACC
ATGGCTGATCTGTGCTTGGTGCCTCAGGTGGCAAATGCTGAAAGATTCAAGGTGGATCTC
ACCCCCTACCCTACCATCAGCTCCATCAACAAGAGGCTGCTGGTCTTGGAGGCCTTCCAG
GTGTCTCACCCCTGCCGGCAGCCAGATACACCCACTGAGCTGAGGGCCTAG

# Drug_Target_22_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_22_General_References:
10373324	Fernandez-Canon JM, Hejna J, Reifsteck C, Olson S, Grompe M: Gene structure, chromosomal location, and expression pattern of maleylacetoacetate isomerase. Genomics. 1999 Jun 15;58(3):263-9.
10739172	Blackburn AC, Tzeng HF, Anders MW, Board PG: Discovery of a functional polymorphism in human glutathione transferase zeta by expressed sequence tag database analysis. Pharmacogenetics. 2000 Feb;10(1):49-57.
11327815	Polekhina G, Board PG, Blackburn AC, Parker MW: Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry. 2001 Feb 13;40(6):1567-76.
12508121	Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico L, Levy M, Barbe V, de Berardinis V, Ureta-Vidal A, Pelletier E, Vico V, Anthouard V, Rowen L, Madan A, Qin S, Sun H, Du H, Pepin K, Artiguenave F, Robert C, Cruaud C, Bruls T, Jaillon O, Friedlander L, Samson G, Brottier P, Cure S, Segurens B, Aniere F, Samain S, Crespeau H, Abbasi N, Aiach N, Boscus D, Dickhoff R, Dors M, Dubois I, Friedman C, Gouyvenoux M, James R, Madan A, Mairey-Estrada B, Mangenot S, Martins N, Menard M, Oztas S, Ratcliffe A, Shaffer T, Trask B, Vacherie B, Bellemere C, Belser C, Besnard-Gonnet M, Bartol-Mavel D, Boutard M, Briez-Silla S, Combette S, Dufosse-Laurent V, Ferron C, Lechaplais C, Louesse C, Muselet D, Magdelenat G, Pateau E, Petit E, Sirvain-Trukniewicz P, Trybou A, Vega-Czarny N, Bataille E, Bluet E, Bordelais I, Dubois M, Dumont C, Guerin T, Haffray S, Hammadi R, Muanga J, Pellouin V, Robert D, Wunderle E, Gauguet G, Roy A, Sainte-Marthe L, Verdier J, Verdier-Discala C, Hillier L, Fulton L, McPherson J, Matsuda F, Wilson R, Scarpelli C, Gyapay G, Wincker P, Saurin W, Quetier F, Waterston R, Hood L, Weissenbach J: The DNA sequence and analysis of human chromosome 14. Nature. 2003 Feb 6;421(6923):601-7. Epub 2003 Jan 1.
9396740	Board PG, Baker RT, Chelvanayagam G, Jermiin LS: Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J. 1997 Dec 15;328 ( Pt 3):929-35.
9417084	Fernandez-Canon JM, Penalva MA: Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J Biol Chem. 1998 Jan 2;273(1):329-37.
9531472	Tong Z, Board PG, Anders MW: Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J. 1998 Apr 15;331 ( Pt 2):371-4.
9925947	Blackburn AC, Woollatt E, Sutherland GR, Board PG: Characterization and chromosome location of the gene GSTZ1 encoding the human Zeta class glutathione transferase and maleylacetoacetate isomerase. Cytogenet Cell Genet. 1998;83(1-2):109-14.

# Drug_Target_22_HGNC_ID:
HGNC:4643

# Drug_Target_22_HPRD_ID:
04785

# Drug_Target_22_ID:
909

# Drug_Target_22_Locus:
14q24.3

# Drug_Target_22_Molecular_Weight:
24182

# Drug_Target_22_Name:
Maleylacetoacetate isomerase

# Drug_Target_22_Number_of_Residues:
216

# Drug_Target_22_PDB_ID:
1FW1

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00043	GST_C
PF02798	GST_N

# Drug_Target_22_Protein_Sequence:
>Maleylacetoacetate isomerase
MQAGKPILYSYFRSSCSWRVRIALALKGIDYKTVPINLIKDRGQQFSKDFQALNPMKQVP
TLKIDGITIHQSLAIIEYLEETRPTPRLLPQDPKKRASVRMISDLIAGGIQPLQNLSVLK
QVGEEMQLTWAQNAITCGFNALEQILQSTAGIYCVGDEVTMADLCLVPQVANAERFKVDL
TPYPTISSINKRLLVLEAFQVSHPCRQPDTPTELRA

# Drug_Target_22_Reaction:
RX + glutathione = HX + R-S-glutathione

# Drug_Target_22_Signals:
None

# Drug_Target_22_Specific_Function:
Bifunctional enzyme showing minimal glutathione- conjugating activity with ethacrynic acid and 7-chloro-4- nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Has also low glutathione peroxidase activity with T- butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid

# Drug_Target_22_SwissProt_ID:
O43708

# Drug_Target_22_SwissProt_Name:
MAAI_HUMAN

# Drug_Target_22_Synonyms:
EC 2.5.1.18
EC 5.2.1.2
GSTZ1-1
Glutathione S- transferase zeta 1
MAAI

# Drug_Target_22_Theoretical_pI:
8.71

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Endoplasmic reticulum
endoplasmic reticulum membrane
multi-pass membrane protein. Peroxisome
pero

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
HMGCR

# Drug_Target_23_GenBank_ID_Gene:
M11058

# Drug_Target_23_GenBank_ID_Protein:
306865

# Drug_Target_23_GeneCard_ID:
HMGCR

# Drug_Target_23_Gene_Name:
HMGCR

# Drug_Target_23_Gene_Sequence:
>2667 bp
ATGTTGTCAAGACTTTTTCGAATGCATGGCCTCTTTGTGGCCTCCCATCCCTGGGAAGTC
ATAGTGGGGACAGTGACACTGACCATCTGCATGATGTCCATGAACATGTTTACTGGTAAC
AATAAGATCTGTGGTTGGAATTATGAATGTCCAAAGTTTGAAGAGGATGTTTTGAGCAGT
GACATTATAATTCTGACAATAACACGATGCATAGCCATCCTGTATATTTACTTCCAGTTC
CAGAATTTACGTCAACTTGGATCAAAATATATTTTGGGTATTGCTGGCCTTTTCACAATT
TTCTCAAGTTTTGTATTCAGTACAGTTGTCATTCACTTCTTAGACAAAGAATTGACAGGC
TTGAATGAAGCTTTGCCCTTTTTCCTACTTTTGATTGACCTTTCCAGAGCAAGCACATTA
GCAAAGTTTGCCCTCAGTTCCAACTCACAGGATGAAGTAAGGGAAAATATTGCTCGTGGA
ATGGCAATTTTAGGTCCTACGTTTACCCTCGATGCTCTTGTTGAATGTCTTGTGATTGGA
GTTGGTACCATGTCAGGGGTACGTCAGCTTGAAATTATGTGCTGCTTTGGCTGCATGTCA
GTTCTTGCCAACTACTTCGTGTTCATGACTTTCTTCCCAGCTTGTGTGTCCTTGGTATTA
GAGCTTTCTCGGGAAAGCCGCGAGGGTCGTCCAATTTGGCAGCTCAGCCATTTTGCCCGA
GTTTTAGAAGAAGAAGAAAATAAGCCGAATCCTGTAACTCAGAGGGTCAAGATGATTATG
TCTCTAGGCTTGGTTCTTGTTCATGCTCACAGTCGCTGGATAGCTGATCCTTCTCCTCAA
AACAGTACAGCAGATACTTCTAAGGTTTCATTAGGACTGGATGAAAATGTGTCCAAGAGA
ATTGAACCAAGTGTTTCCCTCTGGCAGTTTTATCTCTCTAAAATGATCAGCATGGATATT
GAACAAGTTATTACCCTAAGTTTAGCTCTCCTTCTGGCTGTCAAGTACATCTTCTTTGAA
CAAACAGAGACAGAATCTACACTCTCATTAAAAAACCCTATCACATCTCCTGTAGTGACA
CAAAAGAAAGTCCCAGACAATTGTTGTAGACGTGAACCTATGCTGGTCAGAAATAACCAG
AAATGTGATTCAGTAGAGGAAGAGACAGGGATAAACCGAGAAAGAAAAGTTGAGGTTATA
AAACCCTTAGTGGCTGAAACAGATACCCCAAACAGAGCTACATTTGTGGTTGGTAACTCC
TCCTTACTCGATACTTCATCAGTACTGGTGACACAGGAACCTGAAATTGAACTTCCCAGG
GAACCTCGGCCTAATGAAGAATGTCTACAGATACTTGGGAATGCAGAGAAAGGTGCAAAA
TTCCTTAGTGATGCTGAGATCATCCAGTTAGTCAATGCTAAGCATATCCCAGCCTACAAG
TTGGAAACTCTGATGGAAACTCATGAGCGTGGTGTATCTATTCGCCGACAGTTACTTTCC
AAGAAGCTTTCAGAACCTTCTTCTCTCCAGTACCTACCTTACAGGGATTATAATTACTCC
TTGGTGATGGGAGCTTGTTGTGAGAATGTTATTGGATATATGCCCATCCCTGTTGGAGTG
GCAGGACCCCTTTGCTTAGATGAAAAAGAATTTCAGGTTCCAATGGCAACAACAGAAGGT
TGTCTTGTGGCCAGCACCAATAGAGGCTGCAGAGCAATAGGTCTTGGTGGAGGTGCCAGC
AGCCGAGTCCTTGCAGATGGGATGACTCGTGGCCCAGTTGTGCGTCTTCCACGTGCTTGT
GACTCTGCAGAAGTGAAAGCCTGGCTCGAAACATCTGAAGGGTTCGCAGTGATAAAGGAG
GCATTTGACAGCACTAGCAGATTTGCACGTCTACAGAAACTTCATACAAGTATAGCTGGA
CGCAACCTTTATATCCGTTTCCAGTCCAGGTCAGGGGATGCCATGGGGATGAACATGATT
TCAAAGGGTACAGAGAAAGCACTTTCAAAACTTCACGAGTATTTCCCTGAAATGCAGATT
CTAGCCGTTAGTGGTAACTATTGTACTGACAAGAAACCTGCTGCTATAAATTGGATAGAG
GGAAGAGGAAAATCTGTTGTTTGTGAAGCTGTCATTCCAGCCAAGGTTGTCAGAGAAGTA
TTAAAGACTACCACAGAGGCTATGATTGAGGTCAACATTAACAAGAATTTAGTGGGCTCT
GCCATGGCTGGGAGCATAGGAGGCTACAACGCCCATGCAGCAAACATTGTCACCGCCATC
TACATTGCCTGTGGACAGGATGCAGCACAGAATGTTGGTAGTTCAAACTGTATTACTTTA
ATGGAAGCAAGTGGTCCCACAAATGAAGATTTATATATCAGCTGCACCATGCCATCTATA
GAGATAGGAACGGTGGGTGGTGGGACCAACCTACTACCTCAGCAAGCCTGTTTGCAGATG
CTAGGTGTTCAAGGAGCATGCAAAGATAATCCTGGGGAAAATGCCCGGCAGCTTGCCCGA
ATTGTGTGTGGGACCGTAATGGCTGGGGAATTGTCACTTATGGCAGCATTGGCAGCAGGA
CATCTTGTCAAAAGTCACATGATTCACAACAGGTCGAAGATCAATTTACAAGACCTCCAA
GGAGCTTGCACCAAGAAGACAGCCTGA

# Drug_Target_23_General_Function:
Lipid transport and metabolism

# Drug_Target_23_General_References:
10391209	Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999 Jul;22(3):231-8.
10698924	Istvan ES, Palnitkar M, Buchanan SK, Deisenhofer J: Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000 Mar 1;19(5):819-30.
2991281	Luskey KL, Stevens B: Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J Biol Chem. 1985 Aug 25;260(18):10271-7.

# Drug_Target_23_HGNC_ID:
HGNC:5006

# Drug_Target_23_HPRD_ID:
00836

# Drug_Target_23_ID:
631

# Drug_Target_23_Locus:
5q13.3-q14

# Drug_Target_23_Molecular_Weight:
97477

# Drug_Target_23_Name:
3-hydroxy-3-methylglutaryl-coenzyme A reductase

# Drug_Target_23_Number_of_Residues:
888

# Drug_Target_23_PDB_ID:
1HWL

# Drug_Target_23_Pathway:
Alendronate pathway	SMP00095
Atorvastatin Pathway	SMP00131
Cerivastatin Pathway	SMP00111
Fluvastatin Pathway	SMP00119
Ibandronate Pathway	SMP00079
Lovastatin Pathway	SMP00099
Pamidronate Pathway	SMP00117
Pravastatin Pathway	SMP00089
Risedronate Pathway	SMP00112
Rosuvastatin Pathway	SMP00092
Zoledronate Pathway	SMP00107

# Drug_Target_23_Pfam_Domain_Function:
PF00368	HMG-CoA_red

# Drug_Target_23_Protein_Sequence:
>3-hydroxy-3-methylglutaryl-coenzyme A reductase
MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSS
DIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTG
LNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIG
VGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFAR
VLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKR
IEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVT
QKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNS
SLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYK
LETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGV
AGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRAC
DSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMI
SKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREV
LKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITL
MEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLAR
IVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA

# Drug_Target_23_Reaction:
(R)-mevalonate + CoA + 2 NADP+ = (S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH + 2 H+

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
This transmembrane glycoprotein is involved in the control of cholesterol biosynthesis. It is the rate-limiting enzyme of sterol biosynthesis

# Drug_Target_23_SwissProt_ID:
P04035

# Drug_Target_23_SwissProt_Name:
HMDH_HUMAN

# Drug_Target_23_Synonyms:
EC 1.1.1.34
HMG-CoA reductase

# Drug_Target_23_Theoretical_pI:
6.72

# Drug_Target_23_Transmembrane_Regions:
10-39
57-78
90-114
124-149
160-187
192-220
315-339

# Drug_Target_24_Cellular_Location:
Cytoplasmic

# Drug_Target_24_Chromosome_Location:
Not Available

# Drug_Target_24_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_24_Essentiality:
Non-Essential

# Drug_Target_24_GenAtlas_ID:
Not Available

# Drug_Target_24_GenBank_ID_Gene:
X61210

# Drug_Target_24_GenBank_ID_Protein:
48960

# Drug_Target_24_GeneCard_ID:
Not Available

# Drug_Target_24_Gene_Name:
prfA

# Drug_Target_24_Gene_Sequence:
>714 bp
ATGAACGCTCAAGCAGAAGAATTCAAAAAATATTTAGAAACTAACGGGATAAAACCAAAA
CAATTTCATAAAAAAGAACTTATTTTTAACCAATGGGATCCACAAGAATATTGTATTTTT
CTATATGATGGTATCACAAAGCTCACGAGTATTAGCGAGAACGGGACCATCATGAATTTA
CAATACTACAAAGGGGCTTTCGTTATAATGTCTGGCTTTATTGATACAGAAACATCGGTT
GGCTATTATAATTTAGAAGTCATTAGCGAGCAGGCTACCGCATACGTTATCAAAATAAAC
GAACTAAAAGAACTACTGAGCAAAAATCTTACGCACTTTTTCTATGTTTTCCAAACCCTA
CAAAAACAAGTTTCATACAGTCTAGCTAAATTTAATGATTTTTCGATTAACGGGAAGCTT
GGCTCTATTTGCGGTCAACTTTTAATCCTGACCTATGTGTATGGTAAAGAAACTCCTGAT
GGCATCAAGATTACACTGGATAATTTAACAATGCAGGAGTTAGGATATTCAAGTGGCATC
GCACATAGCTCAGCTGTTAGCAGAATTATTTCCAAATTAAAGCAAGAGAAAGTTATCGTG
TATAAAAATTCATGCTTTTATGTACAAAATCTTGATTATCTCAAAAGATATGCCCCTAAA
TTAGATGAATGGTTTTATTTAGCATGTCCTGCTACTTGGGGAAAATTAAATTAA

# Drug_Target_24_General_Function:
Signal transduction mechanisms

# Drug_Target_24_General_References:
11679669	Glaser P, Frangeul L, Buchrieser C, Rusniok C, Amend A, Baquero F, Berche P, Bloecker H, Brandt P, Chakraborty T, Charbit A, Chetouani F, Couve E, de Daruvar A, Dehoux P, Domann E, Dominguez-Bernal G, Duchaud E, Durant L, Dussurget O, Entian KD, Fsihi H, Garcia-del Portillo F, Garrido P, Gautier L, Goebel W, Gomez-Lopez N, Hain T, Hauf J, Jackson D, Jones LM, Kaerst U, Kreft J, Kuhn M, Kunst F, Kurapkat G, Madueno E, Maitournam A, Vicente JM, Ng E, Nedjari H, Nordsiek G, Novella S, de Pablos B, Perez-Diaz JC, Purcell R, Remmel B, Rose M, Schlueter T, Simoes N, Tierrez A, Vazquez-Boland JA, Voss H, Wehland J, Cossart P: Comparative genomics of Listeria species. Science. 2001 Oct 26;294(5543):849-52.
1662763	Mengaud J, Dramsi S, Gouin E, Vazquez-Boland JA, Milon G, Cossart P: Pleiotropic control of Listeria monocytogenes virulence factors by a gene that is autoregulated. Mol Microbiol. 1991 Sep;5(9):2273-83.
2122460	Leimeister-Wachter M, Haffner C, Domann E, Goebel W, Chakraborty T: Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of listeria monocytogenes. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8336-40.
9045810	Ripio MT, Dominguez-Bernal G, Lara M, Suarez M, Vazquez-Boland JA: A Gly145Ser substitution in the transcriptional activator PrfA causes constitutive overexpression of virulence factors in Listeria monocytogenes. J Bacteriol. 1997 Mar;179(5):1533-40.

# Drug_Target_24_HGNC_ID:
Not Available

# Drug_Target_24_HPRD_ID:
Not Available

# Drug_Target_24_ID:
2280

# Drug_Target_24_Locus:
Not Available

# Drug_Target_24_Molecular_Weight:
27302

# Drug_Target_24_Name:
Listeriolysin regulatory protein

# Drug_Target_24_Number_of_Residues:
237

# Drug_Target_24_PDB_ID:
2BEO

# Drug_Target_24_Pathway:
Not Available

# Drug_Target_24_Pfam_Domain_Function:
Not Available

# Drug_Target_24_Protein_Sequence:
>Listeriolysin regulatory protein
MNAQAEEFKKYLETNGIKPKQFHKKELIFNQWDPQEYCIFLYDGITKLTSISENGTIMNL
QYYKGAFVIMSGFIDTETSVGYYNLEVISEQATAYVIKINELKELLSKNLTHFFYVFQTL
QKQVSYSLAKFNDFSINGKLGSICGQLLILTYVYGKETPDGIKITLDNLTMQELGYSSGI
AHSSAVSRIISKLKQEKVIVYKNSCFYVQNLDYLKRYAPKLDEWFYLACPATWGKLN

# Drug_Target_24_Reaction:
Not Available

# Drug_Target_24_Signals:
None

# Drug_Target_24_Specific_Function:
Positively regulates expression of listeriolysin, of 1- phosphadidylinositol phosphodiesterase (PI-PLC) and other virulence factors

# Drug_Target_24_SwissProt_ID:
P22262

# Drug_Target_24_SwissProt_Name:
PRFA_LISMO

# Drug_Target_24_Synonyms:
Not Available

# Drug_Target_24_Theoretical_pI:
8.25

# Drug_Target_24_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AB001488

# Drug_Target_2_GenBank_ID_Protein:
1881272

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
acpS

# Drug_Target_2_Gene_Sequence:
>366 bp
ATGATTTACGGCATTGGGCTGGACATTACCGAGCTTAAACGGATCGCCTCTATGGCTGGG
CGCCAGAAAAGGTTTGCCGAGCGGATTTTGACGCGAAGCGAGCTTGACCAATACTATGAG
CTTTCAGAGAAAAGAAAAAACGAATTTCTCGCGGGCAGATTCGCGGCAAAAGAAGCGTTC
TCGAAAGCATTTGGCACCGGCATTGGGAGGCAGCTCAGCTTTCAGGACATTGAAATTAGG
AAAGACCAAAATGGCAAGCCCTATATCATTTGTACGAAACTGAGCCAGGCCGCCGTTCAC
GTATCGATCACTCATACAAAAGAATACGCTGCCGCGCAGGTTGTGATTGAAAGGTTGTCA
AGCTAG

# Drug_Target_2_General_Function:
Lipid transport and metabolism

# Drug_Target_2_General_References:
11489886	Mootz HD, Finking R, Marahiel MA: 4'-phosphopantetheine transfer in primary and secondary metabolism of Bacillus subtilis. J Biol Chem. 2001 Oct 5;276(40):37289-98. Epub 2001 Aug 6.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3317

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
13718

# Drug_Target_2_Name:
Holo-[acyl-carrier-protein] synthase

# Drug_Target_2_Number_of_Residues:
121

# Drug_Target_2_PDB_ID:
1F7T

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01648	ACPS

# Drug_Target_2_Protein_Sequence:
>Holo-[acyl-carrier-protein] synthase
MIYGIGLDITELKRIASMAGRQKRFAERILTRSELDQYYELSEKRKNEFLAGRFAAKEAF
SKAFGTGIGRQLSFQDIEIRKDQNGKPYIICTKLSQAAVHVSITHTKEYAAAQVVIERLS
S

# Drug_Target_2_Reaction:
CoA-[4'-phosphopantetheine] + apo-[acyl-carrier-protein] = adenosine 3',5'-bisphosphate + holo-[acyl-carrier-protein]

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Transfers the 4'-phosphopantetheine moiety from coenzyme A to a Ser of fatty acid acyl-carrier-protein ACP. Also modifies the D-alanyl carrier protein but fails to recognize PCP and acpK, an acyl carrier protein of secondary metabolism

# Drug_Target_2_SwissProt_ID:
P96618

# Drug_Target_2_SwissProt_Name:
ACPS_BACSU

# Drug_Target_2_Synonyms:
4'-phosphopantetheinyl transferase acpS
EC 2.7.8.7
Holo-ACP synthase

# Drug_Target_2_Theoretical_pI:
10.08

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X13462

# Drug_Target_3_GenBank_ID_Protein:
41709

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
hisD

# Drug_Target_3_Gene_Sequence:
>1305 bp
ATGAGCTTTAACACAATCATTGACTGGAATAGCTGTACTGCGGTGCAACAACGCCAGCTG
TTAATGCGCCCGGCGATTTCCGCCTCTGAAAGCATTACCCGCACTGTTAACGATATTCTC
GATAACGTGAAAGCACGCGGCGATGAGGCCCTGCGGGAATACAGCGCGAAGTTTGATAAA
ACCACGGTTACCGCGCTGAAGGTGTCTGCAGAGGAGATCGCCGCCGCCAGCGAACGCCTG
AGCGACGAGCTAAAACAGGCGATGGCGGTGGCAGTAAAGAATATTGAAACCTTCCACACT
GCGCAAAAACTGCCGCCGGTAGATGTAGAAACGCAGCCAGGCGTGCGTTGCCAGCAGGTC
ACGCGTCCGGTAGCTTCAGTTGGGTTGTATATTCCTGGCGGCTCCGCCCCGCTCTTCTCA
ACGGTATTAATGCTGGCGACTCCGGCGCGTATTGCGGGCTGTAAAAAAGTGGTGCTGTGC
TCACCGCCGCCGATTGCCGATGAGATCCTTTATGCGGCGCAGCTGTGCGGTGTGCAGGAC
GTGTTCAACGTCGGCGGCGCACAGGCCATTGCCGCACTGGCGTTTGGTACGGAATCCGTG
CCAAAAGTGGACAAAATCTTCGGGCCGGGTAACGCCTTTGTCACCGAAGCGAAACGTCAG
GTGAGCCAGCGTCTGGACGGTGCGGCGATCGATATGCCCGCAGGCCCGTCGGAAGTGCTG
GTGATTGCTGACAGCGGCGCAACGCCGGATTTCGTGGCTTCTGATTTGCTCTCTCAGGCT
GAACACGGCCCGGACTCACAGGTGATTTTACTGACGCCCGCTGCTGATATGGCGCGTCGC
GTTGCCGAGGCCGTCGAACGCCAACTGGCGGAACTGCCGCGTGCCGAAACCGCCCGCCAG
GCACTGAACGCCAGCCGCCTGATCGTGACTAAAGATTCAGCGCAGTGCGTGGAGATCTCT
AATCAGTACGGCCCGGAGCACCTGATCATTCAGACCCGCAACGCCCGTGAACTGGTCGAT
AGCATCACCAGCGCCGGTTCGGTATTTCTTGGTGACTGGTCACCGGAATCGGCAGGTGAT
TACGCCTCCGGAACCAACCACGTTCTACCGACTTACGGTTACACCGCCACCTGTTCCAGC
CTCGGGCTGGCAGATTTCCAGAAGCGTATGACCGTACAGGAACTGTCGAAAGAGGGGTTC
TCCGCGGTGGCTTCAACCATAGAAACACTGGCCGCCGCCGAACGTCTGACCGCCCATAAA
AATGCCGTTACCTTGCGCGTTAACGCCCTCAAGGAGCAAGCATGA

# Drug_Target_3_General_Function:
Amino acid transport and metabolism

# Drug_Target_3_General_References:
11842181	Barbosa JA, Sivaraman J, Li Y, Larocque R, Matte A, Schrag JD, Cygler M: Mechanism of action and NAD+-binding mode revealed by the crystal structure of L-histidinol dehydrogenase. Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1859-64. Epub 2002 Feb 12.
2194167	Jovanovic G, Kostic T, Savic DJ: Nucleotide and amino acid polymorphism in the gene for L-histidinol dehydrogenase of Escherichia coli K12. Nucleic Acids Res. 1990 Jun 25;18(12):3634.
3018428	Chiariotti L, Alifano P, Carlomagno MS, Bruni CB: Nucleotide sequence of the Escherichia coli hisD gene and of the Escherichia coli and Salmonella typhimurium hisIE region. Mol Gen Genet. 1986 Jun;203(3):382-8.
3062174	Carlomagno MS, Chiariotti L, Alifano P, Nappo AG, Bruni CB: Structure and function of the Salmonella typhimurium and Escherichia coli K-12 histidine operons. J Mol Biol. 1988 Oct 5;203(3):585-606.
6246067	Bruni CB, Musti AM, Frunzio R, Blasi F: Structural and physiological studies of the Escherichia coli histidine operon inserted into plasmid vectors. J Bacteriol. 1980 Apr;142(1):32-42.
9097040	Itoh T, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Kasai H, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Seki Y, Horiuchi T, et al.: A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40.1-50.0 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):379-92.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3191

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
46111

# Drug_Target_3_Name:
Histidinol dehydrogenase

# Drug_Target_3_Number_of_Residues:
434

# Drug_Target_3_PDB_ID:
1K75

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00815	Histidinol_dh

# Drug_Target_3_Protein_Sequence:
>Histidinol dehydrogenase
MSFNTIIDWNSCTAEQQRQLLMRPAISASESITRTVNDILDNVKARGDEALREYSAKFDK
TTVTALKVSAEEIAAASERLSDELKQAMAVAVKNIETFHTAQKLPPVDVETQPGVRCQQV
TRPVASVGLYIPGGSAPLFSTVLMLATPASIAGCKKVVLCSPPPIADEILYAAQLCGVQD
VFNVGGAQAIAALAFGTESVPKVDKIFGPGNAFVTEAKRQVSQRLDGAAIDMPAGPSEVL
VIADSGATPDFVASDLLSQAEHGPDSQVILLTPAADMARRVAEAVERQLAELPRAETARQ
ALNASRLIVTKDLAQCVEISNQYGPEHLIIQTRNARELVDSITSAGSVFLGDWSPESAGD
YASGTNHVLPTYGYTATCSSLGLADFQKRMTVQELSKEGFSALASTIETLAAAERLTAHK
NAVTLRVNALKEQA

# Drug_Target_3_Reaction:
L-histidinol + 2 NAD+ = L-histidine + 2 NADH + 2 H+

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the sequential NAD-dependent oxidations of L- histidinol to L-histidinaldehyde and then to L-histidine

# Drug_Target_3_SwissProt_ID:
P06988

# Drug_Target_3_SwissProt_Name:
HISX_ECOLI

# Drug_Target_3_Synonyms:
EC 1.1.1.23
HDH

# Drug_Target_3_Theoretical_pI:
4.81

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
Y00710

# Drug_Target_4_GenBank_ID_Protein:
40978

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
aroE

# Drug_Target_4_Gene_Sequence:
>819 bp
ATGGAAACCTATGCTGTTTTTGGTAATCCGATAGCCCACAGCAAATCGCCATTCATTCAT
CAGCAATTTGCTCAGCAACTGAATATTGAACATCCCTATGGGCGCGTGTTGGCACCCATC
AATGATTTCATCAACACACTGAACGCTTTCTTTAGTGCTGGTGGTAAAGGTGCGAATGTG
ACGGTGCCTTTTAAAGAAGAGGCTTTTGCCAGAGCGGATGAGCTTACTGAACGGGCAGCG
TTGGCTGGTGCTGTTAATACCCTCATGCGGTTAGAAGATGGACGCCTGCTGGGTGACAAT
ACCGATGGTGTAGGCTTGTTAAGCGATCTGGAACGTCTGTCTTTTATCCGCCCTGGTTTA
CGTATTCTGCTTATCGGCGCTGGTGGAGCATCTCGCGGCGTACTACTGCCACTCCTTTCC
CTGGACTGTGCGGTGACAATAACTAATCGGACGGTATCCCGCGCGGAAGAGTTGGCTAAA
TTGTTTGCGCACACTGGCAGTATTCAGGCGTTGAGTATGGACGAACTGGAAGGTCATGAG
TTTGATCTCATTATTAATGCAACATCCAGTGGCATCAGTGGTGATATTCCGGCGATCCCG
TCATCGCTCATTCATCCAGGCATTTATTGCTATGACATGTTCTATCAGAAAGGAAAAACT
CCTTTTCTGGCATGGTGTGAGCAGCGAGGCTCAAAGCGTAATGCTGATGGTTTAGGAATG
CTGGTGGCACAGGCGGCTCATGCCTTTCTTCTCTGGCACGGTGTTCTGCCTGACGTAGAA
CCAGTTATAAAGCAATTGCAGGAGGAATTGTCCGCGTGA

# Drug_Target_4_General_Function:
Amino acid transport and metabolism

# Drug_Target_4_General_References:
10739937	Maclean J, Campbell SA, Pollock K, Chackrewarthy S, Coggins JR, Lapthorn AJ: Crystallization and preliminary X-ray analysis of shikimate dehydrogenase from Escherichia coli. Acta Crystallogr D Biol Crystallogr. 2000 Apr;56(Pt 4):512-5.
3277621	Anton IA, Coggins JR: Sequencing and overexpression of the Escherichia coli aroE gene encoding shikimate dehydrogenase. Biochem J. 1988 Jan 15;249(2):319-26.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
3515

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
29414

# Drug_Target_4_Name:
Shikimate dehydrogenase

# Drug_Target_4_Number_of_Residues:
272

# Drug_Target_4_PDB_ID:
1NYT

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01488	Shikimate_DH
PF08501	Shikimate_dh_N

# Drug_Target_4_Protein_Sequence:
>Shikimate dehydrogenase
METYAVFGNPIAHSKSPFIHQQFAQQLNIEHPYGRVLAPINDFINTLNAFFSAGGKGANV
TVPFKEEAFARADELTERAALAGAVNTLMRLEDGRLLGDNTDGVGLLSDLERLSFIRPGL
RILLIGAGGASRGVLLPLLSLDCAVTITNRTVSRAEELAKLFAHTGSIQALSMDELEGHE
FDLIINATSSGISGDIPAIPSSLIHPGIYCYDMFYQKGKTPFLAWCEQRGSKRNADGLGM
LVAQAAHAFLLWHGVLPDVEPVIKQLQEELSA

# Drug_Target_4_Reaction:
shikimate + NADP+ = 3-dehydroshikimate + NADPH + H+

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Shikimate + NADP(+) = 3-dehydroshikimate + NADPH

# Drug_Target_4_SwissProt_ID:
P15770

# Drug_Target_4_SwissProt_Name:
AROE_ECOLI

# Drug_Target_4_Synonyms:
EC 1.1.1.25

# Drug_Target_4_Theoretical_pI:
5.31

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
LGALS1

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
7003

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Galectin-1

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
P09382

# Drug_Target_5_SwissProt_Name:
LEG1_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Cell junction, synapse, presynaptic cell membrane (By similarity). Cell junction, synapse (By simila

# Drug_Target_6_Chromosome_Location:
5

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AF145710

# Drug_Target_6_GenBank_ID_Protein:
4836793

# Drug_Target_6_GeneCard_ID:
CAMK2A

# Drug_Target_6_Gene_Name:
CAMK2A

# Drug_Target_6_Gene_Sequence:
>1437 bp
ATGGCTACCATCACCTGCACCCGCTTCACGGAAGAGTACCAGCTCTTCGAGGAATTGGGC
AAGGGAGCCTTCTCGGTGGTGCGAAGGTGTGTGAAGGTGCTGGCTGGCCAGGAGTATGCT
GCCAAGATCATCAACACAAAGAAGCTGTCAGCCAGAGACCATCAGAAGCTGGAGCGTGAA
GCCCGCATCTGCCGCCTGCTGAAGCACCCCAACATCGTCCGACTACATGACAGCATCTCA
GAGGAGGGACACCACTACCTGATCTTCGACCTGGTCACTGGTGGGGAACTGTTTGAAGAT
ATCGTGGCCCGGGAGTATTACAGTGAGGCGGATGCCAGTCACTGTATCCAGCAGATCCTG
GAGGCTGTGCTGCACTGCCACCAGATGGGGGTGGTGCACCGGGACCTGAAGCCTGAGAAT
CTGTTGCTGGCCTCCAAGCTCAAGGGTGCCGCAGTGAAGCTGGCAGACTTTGGCCTGGCC
ATAGAGGTGGAGGGGGAGCAGCAGGCATGGTTTGGGTTTGCAGGGACTCCTGGATATCTC
TCCCCAGAAGTGCTGCGGAAGGACCCGTACGGGAAGCCTGTGGACCTGTGGGCTTGTGGG
GTCATCCTGTACATCCTGCTGGTTGGGTACCCCCCGTTCTGGGATGAGGACCAGCACCGC
CTGTACCAGCAGATCAAAGCCGGCGCCTATGATTTCCCATCGCCGGAATGGGACACTGTC
ACCCCGGAAGCCAAGGATCTGATCAATAAGATGCTGACCATTAACCCATCCAAACGCATC
ACAGCTGCCGAAGCCCTTAAGCACCCCTGGATCTCGCACCGCTCCACCGTGGCATCCTGC
ATGCACAGACAGGAGACCGTGGACTGCCTGAAGAAGTTCAATGCCAGGAGGAAACTGAAG
GGAGCCATTCTCACCACGATGCTGGCCACCAGGAACTTCTCCGGAGGGAAGAGTGGGGGA
AACAAGAAGAGCGATGGTGTGAAGGAATCCTCAGAGAGCACCAACACCACCATCGAGGAT
GAAGACACCAAAGTGCGGAAACAGGAAATTATAAAAGTGACAGAGCAGCTGATTGAAGCC
ATAAGCAATGGAGGTTTTGAGTCCTACACGAAGATGTGCGACCCTGGCATGACAGCCTTC
GAACCTGAGGCCCTGGGGAACCTGGTTGAGGGCCTGGACTTCCATCGATTCTATTTTGAA
AACCTGTGGTCCCGGAACAGCAAGCCCGTGCACACCACCATCCTGAATCCCCACATCCAC
CTGATGGGCGACGAGTCAGCCTGCATCGCCTACATCCGCATCACGCAGTACCTGGACGCT
GGCGGCATCCCACGCACCGCCCAGTCGGAGGAGACCCGTGTCTGGCACCGCCGGGACGGC
AAATGGCAGATCGTCCACTTCCACAGATCTGGGGCGCCCTCCGTCCTGCCCCATTGA

# Drug_Target_6_General_Function:
Involved in ATP binding

# Drug_Target_6_General_References:
10231032	Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O: Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1999 Feb 26;6(1):63-70.
15312654	Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE: SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron. 2004 Aug 19;43(4):563-74.

# Drug_Target_6_HGNC_ID:
GNC:1460

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6579

# Drug_Target_6_Locus:
5q32

# Drug_Target_6_Molecular_Weight:
54029.2

# Drug_Target_6_Name:
Calcium/calmodulin-dependent protein kinase type II alpha chain

# Drug_Target_6_Number_of_Residues:
478

# Drug_Target_6_PDB_ID:
1HKX

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00069	Pkinase
PF08332	CaMKII_AD

# Drug_Target_6_Protein_Sequence:
>Calcium/calmodulin-dependent protein kinase type II alpha chain
MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLERE
ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL
EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL
SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV
TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK
GAILTTMLATRNFSGGKSGGNKKSDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEA
ISNGGFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIH
LMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
CaM-kinase II (CAMK2) is a prominent kinase in the central nervous system that may function in long-term potentiation and neurotransmitter release. Member of the NMDAR signaling complex in excitatory synapses it may regulate NMDAR-dependent potentiation of the AMPAR and synaptic plasticity (By similarity)

# Drug_Target_6_SwissProt_ID:
Q9UQM7

# Drug_Target_6_SwissProt_Name:
KCC2A_HUMAN

# Drug_Target_6_Synonyms:
CaM kinase II subunit alpha
CaM-kinase II alpha chain
CaMK-II subunit alpha

# Drug_Target_6_Theoretical_pI:
7.20

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AP008226

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
rpmA

# Drug_Target_7_Gene_Sequence:
>258 bp
TTAGGCCAAGGGGCGCACGTGAACGTACCGACCGAGACGGCCCCGGTCCTGGAACTCCAC
CACCCCGTCCACCAGGGCGAAGAGGGTGAAGTCCCGGCCCATGCCCACGTTCTTGCCGGG
CTTGAACCTGGTGCCCCGCTGGCGCACCAGGATGTTGCCCGCCCGGACCACCTGGCCCTC
GTACCGCTTGACCCCGAGGCGCTTGGCCTGGGAGTCGCGGCCGTTCCTCGTGGAACCTAG
ACCCTTTTTATGCGCCAT

# Drug_Target_7_General_Function:
Involved in structural constituent of ribosome

# Drug_Target_7_General_References:
11283358	Yusupov MM, Yusupova GZ, Baucom A, Lieberman K, Earnest TN, Cate JH, Noller HF: Crystal structure of the ribosome at 5.5 A resolution. Science. 2001 May 4;292(5518):883-96. Epub 2001 Mar 29.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5669

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
9508

# Drug_Target_7_Name:
50S ribosomal protein L27

# Drug_Target_7_Number_of_Residues:
85

# Drug_Target_7_PDB_ID:
1V8Q

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF01016	Ribosomal_L27

# Drug_Target_7_Protein_Sequence:
>50S ribosomal protein L27
MAHKKGLGSTRNGRDSQAKRLGVKRYEGQVVRAGNILVRQRGTRFKPGKNVGMGRDFTLF
ALVDGVVEFQDRGRLGRYVHVRPLA

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Found on the solvent side of the large subunit

# Drug_Target_7_SwissProt_ID:
P60493

# Drug_Target_7_SwissProt_Name:
RL27_THET8

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
12.19

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasm

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
ALDH1A1

# Drug_Target_8_GenBank_ID_Gene:
M31994

# Drug_Target_8_GenBank_ID_Protein:
178372

# Drug_Target_8_GeneCard_ID:
ALDH1A1

# Drug_Target_8_Gene_Name:
ALDH1A1

# Drug_Target_8_Gene_Sequence:
>1506 bp
ATGTCATCCTCAGGCACGCCAGACTTACCTGTCCTACTCACCGATTTGAAGATTCAATAT
ACTAAGATCTTCATAAACAATGAATGGCATGATTCAGTGAGTGGCAAGAAATTTCCTGTC
TTTAATCCTGCAACTGAGGAGGAGCTCTGCCAGGTAGAAGAAGGAGATAAGGAGGATGTT
GACAAGGCAGTGAAGGCCGCAAGACAGGCTTTTCAGATTGGATCTCCGTGGCGTACTATG
GATGCTTCCGAGAGGGGGCGACTATTATACAAGTTGGCTGATTTAATCGAAAGAGATCGT
CTGCTGCTGGCGACAATGGAGTCAATGAATGGTGGAAAACTCTATTCCAATGCATATCTG
AATGATTTAGCAGGCTGCATCAAAACATTGCGCTACTGTGCAGGTTGGGCTGACAAGATC
CAGGGCCGTACAATACCAATTGATGGAAATTTTTTTACATATACAAGACATGAACCTATT
GGTGTATGTGGCCAAATCATTCCTTGGAATTTCCCGTTGGTTATGCTCATTTGGAAGATA
GGGCCTGCACTGAGCTGTGGAAACACAGTGGTTGTCAAACCAGCAGAGCAAACTCCTCTC
ACTGCTCTCCACGTGGCATCTTTAATAAAAGAGGCAGGGTTTCCTCCTGGAGTAGTGAAT
ATTGTTCCTGGTTATGGGCCTACAGCAGGGGCAGCCATTTCTTCTCACATGGATATAGAC
AAAGTAGCCTTCACAGGATCAACAGAGGTTGGCAAGTTGATCAAAGAAGCTGCCGGGAAA
AGCAATCTGAAGAGGGTGACCCTGGAGCTTGGAGGAAAGAGCCCTTGCATTGTGTTAGCT
GATGCCGACTTGGACAATGCTGTTGAATTTGCACACCATGGGGTATTCTACCACCAGGGC
CAGTGTTGTATAGCCGCATCCAGGATTTTTGTGGAAGAATCAATTTATGATGAGTTTGTT
CGAAGGAGTGTTGAGCGGGCTAAGAAGTATATCCTTGGAAATCCTCTGACCCCAGGAGTC
ACTCAAGGCCCTCAGATTGACAAGGAACAATATGATAAAATACTTGACCTCATTGAGAGT
GGGAAGAAAGAAGGGGCCAAACTGGAATGTGGAGGAGGCCCGTGGGGGAATAAAGGCTAC
TTTGTCCAGCCCACAGTGTTCTCTAATGTTACAGATGAGATGCGCATTGCCAAAGAGGAG
ATTTTTGGACCAGTGCAGCAAATCATGAAGTTTAAATCTTTAGATGACGTGATCAAAAGA
GCAAACAATACTTTCTATGGCTTATCAGCAGGAGTGTTTACCAAAGACATTGATAAAGCC
ATAACAATCTCCTCTGCTCTGCAGGCAGGAACAGTGTGGGTGAATTGCTATGGCGTGGTA
AGTGCCCAGTGCCCCTTTGGTGGATTCAAGATGTCTGGAAATGGAAGAGAACTGGGAGAG
TACGGTTTCCATGAATATACAGAGGTCAAAACAGTCACAGTGAAAATCTCTCAGAAGAAC
TCATAA

# Drug_Target_8_General_Function:
Energy production and conversion

# Drug_Target_8_General_References:
2591967	Hsu LC, Chang WC, Yoshida A: Genomic structure of the human cytosolic aldehyde dehydrogenase gene. Genomics. 1989 Nov;5(4):857-65.
2776714	Agarwal DP, Cohn P, Goedde HW, Hempel J: Aldehyde dehydrogenase from human erythrocytes: structural relationship to the liver cytosolic isozyme. Enzyme. 1989;42(1):47-52.
2987944	Hsu LC, Tani K, Fujiyoshi T, Kurachi K, Yoshida A: Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3771-5.
3676276	Abriola DP, Fields R, Stein S, MacKerell AD Jr, Pietruszko R: Active site of human liver aldehyde dehydrogenase. Biochemistry. 1987 Sep 8;26(18):5679-84.
4015823	Yoshida A, Ikawa M, Hsu LC, Tani K: Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases. Alcohol. 1985 Jan-Feb;2(1):103-6.
6723659	Hempel J, von Bahr-Lindstrom H, Jornvall H: Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme. Eur J Biochem. 1984 May 15;141(1):21-35.
8214422	Zheng CF, Wang TT, Weiner H: Cloning and expression of the full-length cDNAS encoding human liver class 1 and class 2 aldehyde dehydrogenase. Alcohol Clin Exp Res. 1993 Aug;17(4):828-31.
8493914	Yoshida A, Hsu LC, Yanagawa Y: Biological role of human cytosolic aldehyde dehydrogenase 1: hormonal response, retinal oxidation and implication in testicular feminization. Adv Exp Med Biol. 1993;328:37-44.

# Drug_Target_8_HGNC_ID:
HGNC:402

# Drug_Target_8_HPRD_ID:
00001

# Drug_Target_8_ID:
611

# Drug_Target_8_Locus:
9q21.13

# Drug_Target_8_Molecular_Weight:
54731

# Drug_Target_8_Name:
Retinal dehydrogenase 1

# Drug_Target_8_Number_of_Residues:
500

# Drug_Target_8_PDB_ID:
1BXS

# Drug_Target_8_Pathway:
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_8_Pfam_Domain_Function:
PF00171	Aldedh

# Drug_Target_8_Protein_Sequence:
>Retinal dehydrogenase 1
SSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVD
KAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLN
DLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIG
PALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDK
VAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQ
CCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESG
KKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRA
NNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEY
GFHEYTEVKTVTVKISQKNS

# Drug_Target_8_Reaction:
retinal + NAD+ + H2O = retinoate + NADH + 2 H+

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Binds free retinal and cellular retinol-binding protein- bound retinal. Can convert/oxidize retinaldehyde to retinoic acid

# Drug_Target_8_SwissProt_ID:
P00352

# Drug_Target_8_SwissProt_Name:
AL1A1_HUMAN

# Drug_Target_8_Synonyms:
ALDH-E1
ALHDII
Aldehyde dehydrogenase family 1 member A1
Aldehyde dehydrogenase, cytosolic
EC 1.2.1.36
RALDH 1
RalDH1

# Drug_Target_8_Theoretical_pI:
6.71

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AE004091

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
ohr

# Drug_Target_9_Gene_Sequence:
>429 bp
ATGCAAACCATCAAGGCTCTCTACACCGCAACCGCAACCGCCACCGGAGGCCGTGACGGC
CGTGCGGTATCCTCGGACGGCGTGCTCGACGTGAAACTCAGCACTCCGCGCGAACTGGGC
GGCCAGGGCGGCGCGGCCACCAACCCGGAACAACTGTTCGCCGCCGGCTACTCCGCCTGC
TTCATCGGAGCCCTGAAGTTCGTTGCCGGCCAGCGCAAGCAGACCCTTCCCGCCGACGCC
TCGATAACCGGCAAGGTCGGCATCGGCCAGATTCCCGGCGGCTTCGGCCTGGAGGTCGAA
CTGCACATCAACCTGCCGGGCCTGGAGCGCGAAGCCGCCGAAGCGCTGGTAGCCGCCGCC
CACCAGGTCTGCCCCTACTCCAACGCTACCCGCGGCAATATCGACGTACGCCTGAACGTG
TCGGTCTGA

# Drug_Target_9_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_9_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
12485986	Lesniak J, Barton WA, Nikolov DB: Structural and functional characterization of the Pseudomonas hydroperoxide resistance protein Ohr. EMBO J. 2002 Dec 16;21(24):6649-59.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
5670

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
14523

# Drug_Target_9_Name:
Organic hydroperoxide resistance protein

# Drug_Target_9_Number_of_Residues:
142

# Drug_Target_9_PDB_ID:
1N2F

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF02566	OsmC

# Drug_Target_9_Protein_Sequence:
>Organic hydroperoxide resistance protein
MQTIKALYTATATATGGRDGRAVSSDGVLDVKLSTPRELGGQGGAATNPEQLFAAGYSAC
FIGALKFVAGQRKQTLPADASITGKVGIGQIPGGFGLEVELHINLPGLEREAAEALVAAA
HQVCPYSNATRGNIDVRLNVSV

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q9HZZ3

# Drug_Target_9_SwissProt_Name:
Q9HZZ3_PSEAE

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
7.41

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB04447
